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Abstract
Understanding the relationship between genomic markers and complex disease could have a pro-
found impact on medicine, but the large number of potential markers can make it hard to differentiate true
biological signal from noise and false positive associations.
A standard approach for relating genetic markers to complex disease is to test each marker for its
association with disease outcome by comparing disease cases to healthy controls. It would be cost-effective
to use control groups across studies of many different diseases; however, this can be problematic when
the controls are genotyped on a platform different from the one used for cases. Since different platforms
genotype different SNPs, imputation is needed to provide full genomic coverage, but introduces differential
measurement error. In Chapter 1, we consider the effects of this differential error on association tests. We
quantify the inﬂation in Type I Error by comparing two healthy control groups drawn from the same cohort
study but genotyped on different platforms, and assess several methods for mitigating this error.
Analyzing genomic data one marker at a time can effectively identify associations, but the resulting
lists of signiﬁcant SNPs or differentially expressed genes can be hard to interpret. Integrating prior biolog-
ical knowledge into risk prediction with such data by grouping genomic features into pathways reduces
the dimensionality of the problem and could improve models by making them more biologically grounded
and interpretable. The kernel machine framework has been proposed to model pathway effects because it
allows nonlinear associations between the genes in a pathway and disease risk. In Chapter 2, we propose
kernel machine regression under the accelerated failure time model. We derive a pseudo-score statistic for
testing and a risk score for prediction using genes in a single pathway. We propose omnibus procedures
that alleviate the need to prespecify the kernel and allow the data to drive the complexity of the resulting
model. In Chapter 3, we extend methods for risk prediction using a single pathway to methods for risk
prediction model using multiple pathways using a multiple kernel learning approach to select important
pathways and efﬁciently combine information across pathways.
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1Abstract
Including previously-genotyped controls in a genome-wide association study can provide cost-savings, but
can also create design biases. When cases and controls are genotyped on different platforms, the imputation
needed to provide genome-wide coverage will introduce differential measurement error and may lead to
false positives. We compared genotype frequencies of two healthy control groups from the Nurses’ Health
Study genotyped on different platforms (Affymetrix 6.0 [n=1,672] and Illumina HumanHap550 [n=1,038]).
Using standard imputation quality ﬁlters, we observed 9,841 SNPs out of 2,347,809 (0.4%) signiﬁcant at the
5 × 10−8 level. We explored three methods for controlling for this Type I error inﬂation. One method was
to remove platform effects using principal components; another was to restrict to SNPs of highest quality
imputation; and a third was to genotype some controls alongside cases to exclude SNPs that are statistical
artifact. The ﬁrst method could not reduce the Type I error rate; the other two could dramatically reduce the
error rate, although both required that a portion of SNPs be excluded from analysis. Ideally, the biases we
describe would be eliminated at the design stage, by genotyping sufﬁcient numbers of cases and controls
on each platform. Researchers using imputation to combine samples genotyped on different platforms with
severely unbalanced case-control ratios should be aware of the potential for inﬂated Type I error rates and
apply appropriate quality ﬁlters. Every SNP found with genome-wide signiﬁcance should be validated on
another platform to verify that its signiﬁcance is not an artifact of study design.
21.1 Introduction
A population-based genome-wide association (GWA) study requires thousands of cases and controls in
order to detect moderate associations between SNPs and disease, and each person genotyped can cost
hundredsofdollars. Thus, whenresearchersplannumerousGWAstudiesfordifferentdiseases, itwouldbe
attractive to use the same healthy control group for more than one disease if all cases are being drawn from
the same underlying population. The Wellcome Trust Case Control Consortium (WTCCC) demonstrated
the effectiveness of this approach by comparing case groups of 7 major diseases to a shared control group
(Wellcome Trust Case Control Consortium, 2007). Additionally, researchers may want to bring in publicly
available controls to increase power without increasing cost. Zhuang et al. (2010) advocated this approach,
andHoandLange(2010)didextensivesimulationsinthisveinthatdemonstratethepotentialimprovement
in power. Ho and Lange provided some examples of studies that have augmented their control groups with
publicly available controls (Hom et al., 2008; Wrensch et al., 2009).
A complication in the reuse of control groups or the inclusion of external controls arises when inves-
tigators wish to genotype cases on a platform different from the one used for controls. This may easily
happen as genotyping technology changes and new chips with new pricing plans become available. It can
appear necessary when funding is too limited to support a sufﬁciently powered study with both cases and
controls genotyped together. Moreover, even if funding exists to genotype or re-genotype a control group
on a particular chip, there may be limited biological samples available for use, or a desire to conserve such
samples. However, while each platform genotypes a collection of tagging SNPs, different platforms choose
these tagging SNPs in different ways. For example, Illumina uses patterns of linkage disequilibrium in
the HapMap to choose its tagging SNPs, while Affymetrix (Affy) provides a large but less determinate
collection of SNPs designed to give good coverage of the entire genome. There is not necessarily much
overlap between the SNPs genotyped on two different platforms. For example, there were 140,325 SNPs in
the overlap between the 508,123 markers on the Illumina HumanHap550 chip and the 606,625 markers on
the Affymetrix Genome-Wide Human 6.0 array we use in this study. Thus, if we restricted to SNPs in the
overlap, we would drop about three-quarters of the SNPs we have available on each of these chips.
When pooling genotype data from different platforms, investigators could impute the SNPs missing
on each platform to get a data set with comparable variables. This approach has been suggested as a way of
combining study cases and controls with publicly available controls genotyped on a different chip (Zhuang
3et al., 2010). Fallin et al. (2010) used imputation to combine their case-control study, genotyped on Illumina,
with a publicly available case-control study genotyped on Affy. A number of imputation methods exist,
and they have been shown to be very accurate in the typical setting where cases and controls are genotyped
together on the same platform (Li et al., 2010; Howie et al., 2009). However, their performance in the setting
we are discussing here, when cases and controls have been genotyped on different platforms, has been
largely unexplored.
After imputation, investigators run association tests as usual, producing p-values for each SNP and
looking for the most signiﬁcant SNPs. However, the imputation has introduced differential measurement
error: for example, some SNPs are measured almost perfectly (through actual genotyping) among the con-
trols, but measured imperfectly (through imputation based on nearby measured SNPs) among the cases.
Furthermore, the imputation itself may introduce bias. Many imputation programs base the imputation
on a database of known genomes, such as the HapMap. If the minor allele frequency (MAF) of a SNP in
the HapMap differs substantially from the MAF in study data, imputation in cases only or controls only
can yield very different MAFs in cases and controls. This setting has been recognized as potentially prob-
lematic. For example, when discussing combining data from studies using different genotyping platforms,
Li et al. (2010) recommends imputing and doing association tests within platform and then combining the
results using a meta-analysis approach, which cannot be implemented unless each platform has at least
some cases and controls.
Differential error induced by imputation may yield SNPs that appear to differ substantially between
cases and controls purely as a result of the imputation. Past studies have shown that differential genotyping
error between cases and controls can inﬂate Type I error rates (e.g. Moskvina et al., 2006). A recent study by
Sebastiani et al. (2010) which built a model using 150 SNPs to predict longevity has been criticized for not
controlling for different chips used with different frequencies between cases and controls. Critics suspect
that many of the signiﬁcant SNPs it identiﬁed are artifact of differential genotyping errors between these
different chips (Alberts, 2010; Carmichael, 2010).
In this paper, we are concerned with problems occurring one step further down the pipeline. Under
the assumption that markers actually genotyped by each chip are being genotyped with good accuracy,
we investigate how well Type I error rates are maintained after imputation in a study where cases and
controls are genotyped on different platforms. To do this, we used the healthy control groups from two
studies nested within the Nurses’ Health Study: a Type 2 Diabetes (T2D) study genotyped on Affy, and a
4Breast Cancer (BrCa) study genotyped on Illumina. After imputation within each study, we label the T2D
controls “cases” and the BrCa controls “controls,” and ﬁt a logistic regression predicting this case-control
status from each SNP. We expect there to be no substantial genetic differences between these two groups –
so any signiﬁcant differences we see reﬂect a Type I error rate higher than expected.
When we did in fact observe inﬂated Type I error after applying standard imputation quality ﬁlters,
we explored a number of ways to lessen the inﬂation. We ﬁrst considered controlling for platform effect
as we would control for population stratiﬁcation: by using principal components (PCs) as covariates in
logistic regression. However, the platform effect was so strong and confounded with case-control status
that we could not ﬁt the models. Then we considered restricting to SNPs imputed with good accuracy. This
approach yields excellent results, but reduces power by reducing the number of SNPs we can test. Finally,
we considered the possibility of genotyping a small number of additional controls alongside cases on the
new platform, who could be compared to the original controls in a preliminary analysis to identify aberrant
SNPs. This approach yields good results, but requires the additional expense of genotyping more subjects.
1.2 Methods
The BrCa and T2D studies have been described elsewhere (Hunter et al., 2007; Qi et al., 2010). Both studies
were restricted to women of European ancestry. Genotyping in the BrCa study was done on the Illumina
HumanHap550 chip, while the T2D study was genotyped on the Affymetrix Genome-Wide Human 6.0 ar-
ray. We imputed missing genotypes separately within each study using MaCH 1.0, which relies on Markov
chain haplotyping (http://www.sph.umich.edu/csg/yli/mach/index.html) (Li et al., 2009, 2010).
We present results from imputation done separately in the two studies; when the two control groups were
pooled ﬁrst and then the imputation was done, results were similar. The imputations used HapMap Re-
lease 22 (NCBI build 36) as a reference panel. For each unmeasured SNP, we considered both a soft call, or
dosage, imputation, which gives the expected number of rare alleles given the other SNPs available for that
individual and takes values on a continuum between 0 and 2, and a hard call imputation, which gives the
best integral guess for the number of rare alleles, either 0, 1, or 2. We had available 1,038 BrCa controls,
which we labeled “controls,” and 1,672 T2D controls, which we labeled “cases.” SNPs with MAF < 0.025
(calculated using both groups after imputation) or imputation quality R2 < 0.30 (calculated in either group)
were removed.
5We ran a logistic regression for each of m SNPs, modeling the log-odds of being a “case” (Y =1 ) as
a linear function of the number of rare alleles at the locus. That is, for the ith SNP, i =1 ,...,m, with Ai
copies of the rare allele, we ﬁt
log
￿
P(Yi = 1)
1 − P(Yi = 1)
￿
= β0 + β1Ai
where β1 is the effect of SNP i and β0 is an intercept term. We stored the p-value and the χ2 test statistic
for the Wald test of β1. For the soft call genotypes, where Ai is the expected number of rare alleles given
the observed data (0 ≤ Ai ≤ 2), the software mach2dat was used (http://www.sph.umich.edu/csg/
yli/mach/index.html) (Li et al., 2009, 2010). For the hard call genotypes, where Ai ∈ {0,1,2}, we used
the software PLINK version 1.07 (http://pngu.mgh.harvard.edu/purcell/plink) (Purcell et al.,
2007). Figures were generated in the statistical software R version 2.9.0 (R Development Core Team, 2009).
We grouped the SNPs into four categories: SNPs genotyped on both chips; SNPs genotyped on Affy
and imputed for the Illumina controls; SNPs genotyped on Illumina and imputed for the Affy controls; and
SNPs imputed for both groups. The false positives found among SNPs genotyped on both platforms can be
thought of as a baseline error rate against which to compare the other three groups. For each group of SNPs
we summarized the error rates using two quantities: the Genomic Control λ and the percentage of SNPs
with p-value less than 5 × 10−8. For χ2 test statistics Xi,i=1 ,...,m, the Genomic Control λ is deﬁned as
λ = median
i=1,...,m
{Xi}/0.455
where 0.455 is approximately the theoretical median of a χ2
1 distribution (Devlin and Roeder, 1999). Our
model assumes the null distribution of each Xi is χ2
1, so if this assumption is valid, we should have λ ≈ 1.A
value of λ > 1 suggests that the observed variance of the test statistic is larger than the theoretical variance,
which will tend to increase the number of false positives. We also calculated the percentage of SNPs signif-
icant at the 5×10−8 signiﬁcance level, a standard signiﬁcance level used for GWA studies (McCarthy et al.,
2008). Assuming the genotype is measured accurately, we don’t expect genotype frequency differences be-
tween our cases and controls, because they are both samples of healthy women used as control groups for
other studies. Thus, we should see very few SNPs with such signiﬁcant p-values (approximately 1 out of
every 20,000,000 independent tests).
When λ > 1 and the percentage of SNPs signiﬁcant at the 5 × 10−8 level was more than expected in
our null setting, we explored 3 methods for controlling for the error inﬂation:
61.2.1 Method 1
We investigated whether we could capture the platform effect using PCs. To do this, we used EIGENSTRAT
(http://genepath.med.harvard.edu/˜reich/Software.htm) (Patterson et al., 2006; Price et al.,
2006). In a typical application of this program, the ﬁrst few PCs are calculated and included as covariates
in logistic regression to capture and control for population stratiﬁcation. An example in Price et al. (2006)
suggests the possibility of some components capturing lab and batch effects as well. We calculated the
ﬁrst ten PCs and assessed how well they correlated with platform effect. Then we attempted to include
these components as covariates in logistic regression models predicting case-control status from each SNP.
We did this in two ways: ﬁrst, we calculated the PCs using all measured and imputed SNPs; second, we
restricted to SNPs in each of the four categories, and calculated PCs using only those SNPs (e.g., using only
SNPs measured on one chip and imputed in the other).
1.2.2 Method 2
WhenmissinggenotypesareimputedbyMaCH,eachSNPhasanR2 valueassociatedwithitthatquantiﬁes
the quality of the imputation. The R2 value is an estimate of the squared correlation between the imputed
genotype and the actual genotype, so a higher R2 corresponds to a SNP imputed with more certainty.
Standard advice is to restrict to SNPs with R2 > 0.3, which we did (Scott et al., 2007). It is expected that this
will remove 70% of poorly imputed SNPs while keeping 99.5% of better imputed SNPs (Li et al., 2010). To
reduce the error inﬂation in our less standard setting, we considered restricting to SNPs imputed at even
higher quality.
Focusing on SNPs measured on one chip and imputed in the other, we considered removing SNPs
with imputation R2 < 0.5,0.75,0.9,0.95 and 0.99. After thresholding by each value of R2, we calculated
λ and the percentage of SNPs with p<5 × 10−8. We kept track of the number of SNPs still available for
analysis at each threshold.
We also constructed an ROC curve to assess the discriminatory ability of this method. We labeled
SNPs with p<5 × 10−8 as “problematic.” As we varied the R2 threshold between 0 and 1, we compared
how many problematic SNPs were being detected (sensitivity) to how many non-problematic SNPs were
being excluded due to low R2 (1−speciﬁcity).
71.2.3 Method 3
The genotype distributions for some SNPs may differ markedly across platforms due to genotyping artifact
or differences in imputation quality. These differences may be identiﬁed even in relatively small samples.
We explored the possibility of genotyping a small number of additional controls along with the cases, which
could be used to identify and eliminate the problematic SNPs. Researchers would perform a preliminary
analysis comparing the additional controls to the original controls, and any SNP signiﬁcant in this pre-
liminary analysis would be discarded. Researchers could then perform standard association tests between
cases and controls using the remaining SNPs.
We randomly selected 1000 subjects from the 1,038 on Illumina to serve as controls, and 1000 subjects
from the 1,672 on Affy to serve as cases. Then from the remaining 672 subjects on Affy, we selected n ad-
ditional subjects to serve as controls genotyped alongside cases on the Affy platform. We ﬁrst performed
a screening step, in which we compared these n Affy controls to the 1000 Illumina controls and eliminated
SNPs signiﬁcant at level α. Then, restricting to SNPs that passed this screening, we performed the main
analysis, comparing the 1000 Illumina controls to the 1000 Affy cases, and calculated the Genomic control λ
and the percentage of SNPs with p<5×10−8 in this main analysis. We did this calculation for n = 100,300
and 500, and for α =0 .001,0.01,0.1, and 0.2. We also constructed ROC curves to assess the discrimina-
tory ability of this method while varying α, the screening threshold. That is, as we varied the α screening
threshold between 0 and 1, we compared how many problematic SNPs (in the main analysis of 1000 Illu-
mina controls vs. 1000 Affy cases) were being detected to how many non-problematic SNPs were being
excluded.
1.3 Results
Figure 1.1 summarizes the results of a standard logistic regression analysis, where SNPs are grouped by
MAF. For each collection of SNPs, we found the Genomic Control λ (in black) and the percentage of SNPs
with p<5 × 10−8 (in gray). Results from the soft call analysis are shown in solid lines, while those from
the hard call analysis are shown in dashed lines. In Figure 1.1a, we see that λ ≈ 1 among the 139,732 SNPs
measured on both chips, and the percentage of highly signiﬁcant SNPs is close to 0 across all MAFs; the
error measures in this setting are virtually identical whether we use hard call or soft call imputation. Thus,
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Figure 1.1: Black and gray lines represent λ values and the percentages of p-values less than 5 × 10−8,
respectively, for SNPs grouped by minor allele frequency (MAF) in four settings: a SNPs genotyped on both
Affy and Illumina platforms; b SNPs genotyped on Illumina platform and imputed for the Affy controls;
c SNPs genotyped on Affy platform and imputed for the Illumina controls; and d SNPs imputed for both
groups. Solid lines are from soft call analysis and dashed lines are from hard call analysis. Note that in
some places (particularly in panel a) the solid and dashed lines are indistinguishable because the results
from the soft call and hard call analyses were very similar.
9when we consider only the SNPs measured on both chips, we have no evidence from these two measures
that the distribution of the test statistics deviates from the null.
However, among the 357,361 SNPs measured on Illumina and imputed on Affy (Figure 1.1b), we see
an overall increase in λ to 1.6. We see an increase in the percentage of highly signiﬁcant SNPs to 1.3%
when using soft call genotypes, and to 2.1% when using hard call genotypes. Thus, when using hard
call genotypes, 7,644 SNPs are being declared signiﬁcant at the 5 × 10−8 level. These increases are most
prominent among SNPs with low MAF, as shown in the Figure. The Type I error inﬂation is also apparent,
though less dramatic, among the 458,034 SNPs measured on Affy and imputed on Illumina (Figure 1.1c)
where λ =1 .3 overall, and where we are seeing 0.4% highly signiﬁcant SNPs when using soft calls and
0.8% highly signiﬁcant SNPs when using hard calls; we see similar numbers among the 1,392,682 SNPs
imputed in both (Figure 1.1d). Results were largely unchanged when we ﬁrst pooled the two groups and
then imputed.
To try to correct these problems, we applied the three described methods. Here, we present results for
the SNPs measured on Illumina and imputed on Affy for simplicity; results were similar in the other two
problematic cases.
1.3.1 Method 1
We found the ﬁrst ten PCs using hard call genotypes because those are currently supported by EIGEN-
STRAT. We did this once using all SNPs, and once restricting to SNPs measured on Illumina and imputed
on Affy. Results were similar in the two approaches, and results from the latter are shown. The top three
PCs are plotted against one another in Figure 1.2. We see that the second PC completely separates the cases
(i.e., the Affy controls) and controls (the Illumina controls). Thus, when these PCs are included in a logis-
tic regression predicting case-control status, we get a complete separation of data points, and the models
cannot be ﬁt.
1.3.2 Method 2
WeconsideredrestrictingtoSNPsimputedwithincreasinglyhigherquality, asquantiﬁedbytheimputation
R2. Results for the soft call genotypes are shown in Table 1.1. As the R2 threshold was increased, our
summary measures improved; however, this happened at the expense of losing SNPs for analysis, which
10PC 1
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Figure 1.2: Top 3 principal components (PCs), among SNPs genotyped in the Illumina controls and imputed
using hard calls in the Affy controls, plotted against one another. Affy samples are plotted in black; Illumina
samples are plotted in gray.
Table 1.1: Among SNPs genotyped in the Illumina controls and imputed using soft calls among the Affy
controls, values of λ and percentages of SNPs with p<5 × 10−8 when we restrict to SNPs with imputation
quality R2 larger than the given thresholds, as detailed in Method 2. Also listed are the percentages of total
SNPs remaining for analysis at each threshold.
R2 threshold
0.3 0.5 0.75 0.9 0.95 0.99
λ 1.6 1.6 1.4 1.2 1.1 1.04
% SNPs with p<5 × 10−8 1.3 0.87 0.36 0.15 0.09 0.05
% SNPs remaining for analysis 100 97 87 71 59 31
11reﬂects some loss of power. It should also be noted that even at the most stringent threshold listed, R2 >
0.99, when we’ve excluded nearly 70% of the SNPs, there remain 57 SNPs with p<5 × 10−8. Figure 1.3
shows the discriminatory ability of this method as we vary the R2 threshold.
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Figure 1.3: Among SNPs genotyped in the Illumina controls and imputed using soft calls among the Affy
controls, discrimination of the R2 criterion described in Method 2, as the R2-threshold varies. The y-axis
is the sensitivity, the proportion of highly signiﬁcant SNPs which are excluded; the x-axis is 1−speciﬁcity,
the proportion of non-signiﬁcant SNPs which are excluded. R2 threshold choices between 0.3 and 0.99 are
pointed out along the curve.
1.3.3 Method 3
For various thresholds (α =0 .001,0.01,0.1,0.2) and various numbers of additional controls on Affy
(n = 100,300,500) we removed SNPs signiﬁcant at level α in a preliminary analysis comparing the n addi-
tional Affy controls to the 1000 original Illumina controls. We then performed standard logistic regressions
comparing the 1000 Illumina controls to the 1000 Affy cases using the remaining SNPs. The genomic con-
trol λ and the percentage of highly signiﬁcant SNPs were calculated; results for the soft call genotypes are
shown in Table 1.2. As n increased and α increased, our summary measures improved. This again hap-
pened at the expense of losing SNPs for analysis, but not as quickly as in Method 2. Figure 1.4 shows the
discriminatory ability of this method for each n as we vary the α screening threshold.
12Table 1.2: Results from the main analysis comparing 1000 Affy cases and 1000 Illumina controls, among
SNPs remaining after a preliminary screen in which we compare n = 100, 300, or 500 additional controls on
Affy to 1000 controls on Illumina and remove SNPs signiﬁcant at level α, as detailed in Method 3. Among
SNPs genotyped in the Illumina controls and imputed using soft calls among the Affy controls, values of
λ and percentages of SNPs with p<5 × 10−8 are presented, along with the percentages of total SNPs
remaining for analysis at each threshold.
α threshold
0 0.001 0.01 0.1 0.2
100 additional controls
λ 1.5 1.5 1.5 1.4 1.3
% SNPs with p<5 × 10−8 0.83 0.59 0.38 0.11 0.07
% SNPs remaining for analysis 100 100 98 88 78
300 additional controls
λ 1.5 1.5 1.4 1.2 1.2
% SNPs with p<5 × 10−8 0.83 0.14 0.04 0.01 0.002
% SNPs remaining for analysis 100 99 96 85 74
500 additional controls
λ 1.5 1.4 1.4 1.2 1.1
% SNPs with p<5 × 10−8 0.83 0.03 0.01 0.001 0.0004
% SNPs remaining for analysis 100 98 95 82 72
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Figure 1.4: Among SNPs genotyped in the Illumina controls and imputed using soft calls among the Affy
controls, discrimination of the preliminary screening criterion described in Method 3, as the α-threshold
varies. The y-axis is the sensitivity, the proportion of highly signiﬁcant SNPs which are excluded; the x-axis
is 1−speciﬁcity, the proportion of non-signiﬁcant SNPs which are excluded. Plots shown are for a n = 100,
b n = 300, and c n = 500 additional controls. α threshold choices between 0.001 and 0.2 are pointed out
along the curves.
141.4 Discussion
We observed a large number of highly signiﬁcant SNPs after imputation in a study comparing two healthy
control groups genotyped on different platforms. Because both control groups are nested in the NHS and
chosen using similar criteria, we expect no SNPs to signiﬁcantly distinguish the two groups in the absence
of measurement error, and we expect no differential population substructure. Thus, statistically signiﬁcant
SNPs are false positives, and must be due to genotyping or imputation error. Furthermore, because we see
almost no inﬂation in Type I error among SNPs actually genotyped on both chips (Figure 1.1a), the false
positives do not appear to result from genotyping error. Rather, the inﬂation in Type I error is seen among
SNPs measured in one group and imputed in the other (and among SNPs imputed in both). In this setting,
it would be detrimental to avoid imputation altogether since only about a quarter of the SNPs genotyped
on each platform overlap, so that three-quarters of the SNPs on each chip would be unusable without any
imputation. Thus, we need to understand the errors being introduced by imputation and attempt to control
for them.
We believe that the inﬂation in Type I error is due to bias introduced by the differential imputation. The
imputation uses individuals in the HapMap as a reference panel, and it seems plausible that estimates in the
HapMap, particularly for rare alleles, may diverge from the allele frequencies observed in our population.
Thus, if a rare allele has similar frequencies in our cases and controls but is not well covered in the HapMap,
the p-value calculated when the SNP is measured in one group and imputed in the other will tend to be
smaller than the p-value that would arise if that SNP were measured in both groups. Moreover, among
SNPs with low MAF, Moskvina et al. (2006) showed that even modest differential errors in genotype calling
can yield an inﬂation in Type I error. Generalized to our setting, this suggests that even slight differential
errors in imputation among SNPs with low MAF would lead to false positive associations. This is borne
out by our results, where we see larger numbers of highly signiﬁcant p-values among SNPs with low MAF,
as shown in Figure 1.1.
The percentage of highly signiﬁcant SNPs is noticeably larger in the hard call analysis than in the
soft call analysis. This is because the soft call imputations better account for uncertainty in the imputed
values. We recommend using soft calls, or another technique that accounts for imputation uncertainty, in
order to reduce false positives. It is worth considering whether we could somehow alter the imputation
methods themselves to avoid these false positives altogether; however, it is unclear to what extent this is
15possible. Imputation algorithms are limited by the information they are provided. For some platforms, the
genotyped SNPs provide enough information to accurately infer an unobserved SNP; for other platforms,
they do not, regardless of the imputation algorithm. Moreover, current imputation methods have good
accuracy, particularly for SNPs with higher imputation R2 (Li et al., 2010), yet even SNPs with high R2
appear among our false positives. This suggests that even well-imputed SNPs can be falsely signiﬁcant
when the imputation error is differential.
The inﬂation in Type I error appears to be most dramatic among SNPs measured in Illumina and
imputed in Affy. We suspect that this is because Illumina uses HapMap for SNP selection, and we used
HapMap for SNP imputation. When we considered SNPs common to both chips, the distribution of test
statistics was what we expect under the null, suggesting that the actual genotyping across the two chips is
in good agreement.
When we attempted to reduce the error inﬂation using PCs, in Method 1, we observed a complete sep-
aration of the two control groups. This complete separation shows the difﬁculty of controlling for platform
effect by simply adjusting for PCs. Including the PCs as covariates in the model is equivalent to includ-
ing case-control status as a covariate, and thus there does not appear to be a direct way to use those PCs
to resolve the error inﬂation problem. Furthermore, any method using the PCs would likely wash out all
differences between cases and controls in a non-null setting. Thus, it makes sense to focus on approaches
that ﬁlter out problematic SNPs and exclude them from subsequent analysis. Methods 2 and 3 are two such
approaches.
In Method 2, we used imputation quality to ﬁlter SNPs before performing any association tests. This
approach improved the results and does not require genotyping any additional controls. It reduces the
number of SNPs available for analysis, but still allows the use of more SNPs than just those actually geno-
typed on both platforms. However, in our example of SNPs genotyped on Illumina and imputed on Affy,
even after ﬁltering to SNPs imputed with R2 > 0.99 (allowing us to retain only 30% of SNPs), we are left
with 57 SNPs with highly signiﬁcant p-values out of 112,249 remaining SNPs. So if this method is used,
researchers should be prepared to sift through many false positives in a second stage analysis to ﬁnd any
true associations. Furthermore, this method will tend to reduce power to detect SNPs in regions with low
linkage disequilibrium. Beecham et al. (2010) demonstrated this problem by pooling two case-control GWA
studies for Alzheimer disease which had been genotyped on different chips, and testing for associations in
the APOE gene, which is known to be strongly associated with risk. They used imputation to produce com-
16mensurable data sets, and ﬁltered out SNPs according to imputation quality. They found that even though
each study separately found strong associations in the APOE gene, there was no association in the pooled
analysis, because many SNPs had been excluded due to low imputation quality measures caused by weak
linkage disequilibrium in the region.
In Method 3, we propose genotyping a small number of additional controls alongside the cases and
performing a preliminary step of ﬁltering SNPs by comparing these additional controls to the original
controls. This approach also improves results, but at increased monetary cost. It should, however, retain
more non-artifactual SNPs while reducing the number of artifactual SNPs. In our example of 1000 cases and
1000 controls, it appeared that genotyping 300 additional controls alongside cases would allow researchers
to ﬁlter out most of the false positives — with α =0 .2, only 5 highly signiﬁcant SNPs were left among the
SNPs genotyped on Illumina and imputed on Affy, with 264,519 (74%) remaining for analysis. We believe
these results would be the same if we had new cases and controls on Illumina and a separate control group
on Affy — we merely consider this setting because it made best use of the subjects available on each chip.
This method is in line with the discussion in McCarthy et al. (2008) regarding the use of historical controls.
McCarthy et al. listed many possible sources of systematic error that might arise in the use of historical
controls, and recommended always genotyping some ethnically matched controls alongside cases on the
same platform.
It may also be worth considering a related study design in which very little error inﬂation was seen,
which was considered by Howie et al. (2009). In their setting, a central control group in the WTCCC was
genotyped on both Affy and Illumina, while different case groups from different disease studies were geno-
typed on just one of these platforms. The authors were interested in whether imputing SNPs missing in
cases using both the HapMap and the central control group as a reference panel led to inﬂated Type I er-
ror. To assess this, they compared the central control group with another control group genotyped on Affy
alone. They imputed SNPs missing in this new control group and then performed association tests. They
found very few signiﬁcant results, which demonstrated minimal inﬂation of Type I error in this setting.
Their methods differ slightly from ours; however, we believe that the most important difference was the
nested structure of their design – that is, that their central control group had SNPs from both Affy and
Illumina chips, rather than Illumina alone. A comparison of their results and ours suggests that if a central
control group is going to be reused for different diseases, it may be wise to invest in genotyping the central
control group on multiple platforms. A similar conclusion is offered by Marchini and Howie (2010).
17Researchers can make use of accumulating genetic resources to more economically and more power-
fully understand the effects of genes on complex diseases. However, our ﬁndings add to a familiar refrain
about GWA studies – that every step must be done with extreme care to avoid spurious results (McCarthy
et al., 2008). More work needs to be done to determine the best approaches for combining cases and controls
obtained from different sources. In any case-control study, cases and controls should be comparable, and
recent studies have discussed how to control for differential population substructure when using publicly
available controls (Zhuang et al., 2010; Luca et al., 2008). Our work emphasizes the need to control for
technical errors caused by integrating data from different chips. Researchers attempting to use the sort of
data we describe, in which cases and controls are genotyped on different chips, need to be aware of the
high potential for false positives after imputation, and must guard against it or control for it. In particular,
it is vitally important to technically validate any SNPs that appear signiﬁcant before reporting them, by
regenotyping those SNPs on an independent platform – considered best practice in any GWA study, it is all
the more important here where the chance of false positive results due to differential imputation is so high.
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19Abstract
Integrating genomic information with traditional clinical risk factors to improve the prediction of disease
outcomes could profoundly change the practice of medicine. However, the large number of potential mark-
ers and possible complexity of the relationship between markers and disease make it difﬁcult to construct
accurate risk prediction models. Standard approaches for identifying important markers often rely on
marginal associations and may not capture non-linear or interactive effects. In recent years, much work has
been done to group genes into pathways and networks. Integrating such biological knowledge into statis-
tical learning could potentially improve model interpretability and reliability. One effective approach is to
employ a kernel machine (KM) framework, which has been used to make predictions for various types of
outcomes (Scholkopf and Smola, 2002; Liu et al., 2007, 2008). For survival outcomes, regression modeling
and testing procedures have been derived under a proportional hazards (PH) assumption (Li and Luan,
2003; Cai et al., 2011). In this paper, we propose KM regression under the accelerated failure time model,
a useful alternative to the PH model. We derive a pseudo-score statistic for testing and a risk score for
prediction of survival. To approximate the null distribution of our test statistic, we propose resampling
procedures which also enable us to develop alternative robust testing procedures that combine informa-
tion across kernels. Numerical studies show that the testing and prediction procedures perform well. The
methods are illustrated with an application in breast cancer.
202.1 Introduction
Understanding the relationship between genomic markers and complex disease could have a profound im-
pact on biological research, pharmacology, and medicine. Many traditional approaches for quantifying this
relationship identify individual markers with marginal associations with disease; however, resulting lists
of differentially expressed genes can be hard to interpret or replicate, and may not include truly impor-
tant markers with modest, nonlinear, or interactive effects. An appealing alternative is to leverage current
biological knowledge by grouping markers into networks and pathways consisting of genes thought to
work together. Working at the pathway level reduces dimensionality, which decreases the number of sta-
tistical hypotheses to be tested and can improve power to detect associations. Moreover, lists of important
pathways can be easier to interpret than lists of genes because pathways are often deﬁned by known or
hypothesized functions, thus facilitating the generation of mechanistic hypotheses and the identiﬁcation
of potential avenues for intervention. Ideally, pathway methods should identify genes which may indi-
vidually have only modest associations with outcome but which together have a substantial joint effect.
They should also allow for complicated relationships among genes in the pathway that could reﬂect more
complex biological signals.
Kernel machine (KM) methods (Scholkopf and Smola, 2002) are attractive tools for relating biological
pathways to disease outcomes because they can capture complex effects without explicit speciﬁcation of the
form of those effects, and because they can leverage the within-pathway correlation which is likely to exist
in genomic data. For non-censored outcomes, KM regression and testing procedures have been proposed
in Liu et al. (2007) and Liu et al. (2008). For survival outcomes, Li and Luan (2003) and Cai et al. (2011) pro-
posed KM testing and estimation procedures under the proportional hazards (PH) model. However, when
the PH assumption fails to hold, these procedures may have little power to identify important pathways or
accurately predict risk. In this paper, we propose KM methods for survival outcomes under the accelerated
failure time (AFT) model (Kalbﬂeisch et al., 1980), a useful alternative to the PH model.
The standard semiparametric AFT model relates covariates to log-survival time through a linear
model. This model is appealingly interpretable, but has been used less than the Cox model in part be-
cause it can be somewhat challenging to ﬁt in the presence of censoring. Inference procedures for the
regression parameters under the AFT model include the inverse probability weighting (IPW), Buckley-
James, rank-based, and sieve likelihood (SL) methods (Buckley and James, 1979; Koul et al., 1981; Tsiatis,
211990; Wei, 1992; Zeng and Lin, 2007). The IPW approach requires that the conditional censoring distribu-
tion be correctly speciﬁed and that the support of the censoring contain that of the failure time, which are
both unlikely in practice. The Buckley-James procedure relies on the identiﬁability of the entire residual
distribution, which may not be available in the presence of censoring. The SL estimator is fully efﬁcient,
but could be computationally challenging because it requires estimating a non-parametric functional. The
rank-based approach (Tsiatis, 1990; Ritov, 1990), which ﬁts the model using a weighted log rank (WLR)
estimating equation for various weights, has advantages including consistency of estimation without ad-
ditional censoring assumptions, and an effective implementation developed in Jin et al. (2003) for making
inference using resampling.
We propose the use of the AFT KM model to capture potentially complex, non-linear pathway effects
on survival. We ﬁrst develop a pseudo-score test under the KM framework using the WLR estimating
function, using resampling procedures for inference. The WLR weight affects the estimation efﬁciency, and
the kernel determines the structure of the pathway effect, but in practice it is often unclear which weight
or kernel is most appropriate for a given dataset. To overcome this challenge, we propose omnibus testing
procedures that pool information across weights and kernels. We demonstrate the effectiveness of this
approach in simulations, where the power lost by using an omnibus test is minimal, but the power gained
in some circumstances can be substantial.
When a pathway is associated with outcome, we may hope to use the pathway information to improve
risk prediction. Under the AFT KM framework, we propose procedures for estimating the pathway effect
in order to construct individual risk scores. Our simulation results suggest that these outperform those
derived from standard linear effects models when the underlying effects are non-linear, while maintaining
similar accuracy when the effects are linear. Recently, Liu et al. (2010) proposed the usage of the AFT KM
modelandpresentedaweightedleastsquaresestimator. However, inthepresenceofcensoring, itisunclear
whether this estimator is consistent even under linear effects or how they calculate their criterion for tuning
and model assessment, the relative root mean squared error. Because our procedure is derived using the
WLR class of estimating equations, we are guaranteed consistent estimates of the underlying effects when
the AFT model is correctly speciﬁed.
The rest of this paper is organized as follows. In Section 2.2 we introduce the AFT KM model. In
Section2.3wepresenttestingandestimationproceduresusingGehanweightsintheWLR.InSection2.4we
present testing and estimation for general weights, as well as our omnibus testing procedure. Simulations
22are presented in section 2.5 and our method is illustrated in section 2.6 in application to breast cancer data.
Final remarks are in Section 2.7.
2.2 The Kernel Machine Accelerated Failure Time Model
Let T denote the survival time, Z be a P × 1 vector of genetic measurements in a gene set, and D be a
vector of clinical covariates such as age and gender. Due to censoring of T, we observe X =m i n {T,C}
and ∆ = I[T ≤ C], where C is a censoring time that is assumed to be independent of T given W =
(D
T,Z
T)
T. The observed data consist of n independent and identically distributed (iid) random vectors,
O = {(Xi,∆i,Wi):i =1 ,...,n}.
To derive a prediction model for T based on W, we consider the KM generalization of the AFT model:
logTi = γ
TDi + h(Zi)+Ei,i=1 ,...,n. (2.1)
where γ is the unknown covariate effect of Di, Ei is an iid error term independent of Wi with completely
unspeciﬁed distribution, and h(·) is an unknown smooth function that belongs to HK, the Hilbert space
generated by a given positive deﬁnite kernel K(·,·;ρ). The kernel is a measure of similarity between two
vectors of genetic measurements, and may depend on a possibly unknown scaling parameter ρ. Differ-
ent choices of kernel K will yield different collections of possible functions h(·). For example, the lin-
ear kernel K(z1,z2)=z
T
1z2 leads to h(z)=β
Tz, a linear function of the covariates. The quadratic kernel
K(z1,z2;ρ)=( ρ + z
T
1z2)2 yields a Hilbert space HK spanned by basis functions {zj,z jzj￿ : j,j￿ =1 ,...,p},
which incorporates main effects, quadratic effects, and 2-way interactions. To allow for more complex non-
linear effects, one may consider the Gaussian kernel, deﬁned by K(z1,z2;ρ)=e x p {−￿z1 − z2￿2/ρ}. The
resulting function space HK is generated by the radial basis functions.
We will be interested in testing the null hypothesis H0 : h(·) ≡ 0, which suggests that the genes in the
pathway do not affect survival given the covariates D. Under the null, model (2.1) reduces to the standard
AFT model for the clinical covariates,
logTi = γ
TDi + Ei,i=1 ,...,n. (2.2)
As described in Jin et al. (2003), the regression parameter γ can be estimated by solving the WLR estimating
function,
Uφ(γ)=n−1
n ￿
i=1
φ(γ,e i(0;γ))∆i[Di − D(γ,e i(0;γ))] (2.3)
23where ei(0;γ) is the residual ei(h;γ) = logXi − γ
TDi − h(Zi) evaluated at h =0 , φ(γ,t) is a weight func-
tion, and D(γ,t)=S(1)(γ,t)/S(0)(γ,t) for S(k)(γ,t)=n−1 ￿n
j=1 I{ej(0;γ) ≥ t}D
⊗k
j . Here, we use the
notation a⊗0 =1 , a⊗1 = a, and a⊗2 = aa
T for any vector a. Uφ is not componentwise monotonic
in γ in general, but it is when we use the Gehan weights φ = S(0), which yield an estimating function
UG(γ)=n−2 ￿n
i=1
￿n
j=1 ∆i[Di − Dj]I{ej(0;γ) ≥ ei(0;γ)} which is the gradient of the convex Gehan
objective function
LG(γ)=n−2
n ￿
i=1
n ￿
j=1
∆i|ej(0;γ) − ei(0;γ)|+, (2.4)
where |a|+ = aI{a>0}. LG(γ) can be minimized to get an estimator ￿ γG which is consistent for γ in (2.2);
Jin et al. (2003) also provides an iterative procedure to ﬁnd estimators ￿ γφ for general weights φ, which may
be desirable because the variance of ￿ γφ depends on φ.
When we do not assume the pathway effect h(·) is identically 0 in model (2.1), we may obtain estima-
tors for γ and h by minimizing the penalized Gehan objective function analogous to equation (2.4),
LR
G(γ,h)=n−2
n ￿
i=1
n ￿
j=1
∆i|ej(h;γ) − ei(h;γ)|+ +
c2
2
￿h￿2
HK, (2.5)
where ￿h￿HK is the norm of h in HK. By the representer theorem (Kimeldorf and Wahba, 1970), the min-
imizer of LR
G(γ,h) for h must take a dual form, ￿ h(z)=
￿n
l=1 αlK(Zl,z), where the αl are unknown pa-
rameters. Here and in the sequel, we suppress ρ from K for ease of presentation, but note that testing and
estimation may depend on ρ and that tuning ρ will be discussed when needed.
Using the dual representation, minimization of (2.5) is equivalent to minimization of
LR
G(α;γ)=n−2
n ￿
i=1
n ￿
j=1
∆i|ej(α;γ) − ei(α;γ)|+ +
c2
2
α
TKα (2.6)
whereKisthekernelmatrix, whose(i,j)th entryisK(Zi,Zj),and, withaslightabuseofnotation, ei(α;γ)=
logXi−γ
TDi−α
TKi,forKi theith rowofK.Hence, aplug-inestimatorforhmaybeobtainedbyminimizing
LR
G(α;γ) with respect to α and γ. Moreover, we may view (2.6) as the Gehan objective function arising from
the random effects AFT model
logTi = γ
TDi + α
TKi + Ei, α = τ￿,E (￿)=0 , var(￿)=K−, (2.7)
with￿multivariatenormalandc−1 = τ. HereK− istheMoore-PenrosegeneralizedinverseofK.Analogous
connections between penalized KM models and the mixed model framework were successfully used to ﬁt
KM regression in other models (Liu et al., 2007, 2008; Cai et al., 2011).
242.3 Testing and Estimation with Gehan Weights
2.3.1 The Pseudo-Score Statistic
To identify pathways associated with survival, we propose the use of the AFT KM framework and derive
testing procedures for H0 : h(·)=0in model (2.1). Here we derive a KM pseudo-score test of H0 using
the WLR estimating function with Gehan weights; in Section 2.4 we show how to extend the test to more
general weights.
By using the mixed effects formulation (2.7) as a working model, we see that the hypothesis H0 : h(·)=
0 is equivalent to testing H0 : τ =0 , and so we can derive a KM pseudo-score test procedure by writing the
penalized Gehan objective function (2.6) as a function of τ conditional on random effects ￿, LG,￿(τ;γ)+￿
TK￿,
where
LG,￿(τ;γ)=n−2
n ￿
i=1
n ￿
j=1
∆i|ej(τ￿;γ) − ei(τ￿;γ)|+. (2.8)
If γ is known, a pseudo-score statistic can be obtained as
￿ Q(γ)=E￿
￿￿
∇τLG,￿(τ;γ)|τ=0
￿2￿
￿
￿O
￿
,
where ∇τ is the partial derivative with respect to τ. When γ is unknown, as would be the case in
practice, we estimate ￿ γG under the null as described in Section 2.2, and deﬁne our pseudo-score statis-
tic as ￿ Q = ￿ Q(￿ γG). Since ∇τLG,￿(τ;γ)|τ=0 = ￿
TK￿ R(γ), where ￿ R(γ)=( ￿ R1(γ),...,￿ Rn(γ))
T and ￿ Rk(γ)=
n−2 ￿n
j=1 [∆kI{ej(0;γ) ≥ ek(0;γ)} − ∆jI{ek(0;γ) ≥ ej(0;γ)}], we can see that ￿ Q = ￿ R(γ)
TK￿ R(γ). We may
further rewrite this by employing a spectral decomposition for K. If we let the eigenvalues and associated
eigenvectors of K be ￿ λl and ￿ ζl respectively, for l =1 ,...,n,where we assume that ￿ λ1 ≥ ···≥ ￿ λn and that
the ￿ ζl have norm 1, then we may write K = ￿ Bn￿ B
T
n, where ￿ Bn =
￿￿
￿ λ1￿ ζ1 ···
￿
￿ λn￿ ζn
￿
. This allows us to
reexpress ￿ Q(γ) as:
￿ Q(γ)=￿ UG(γ)
T ￿ UG(γ)
where
￿ UG(γ)=￿ B
T
n ￿ R(γ)=n−2
n ￿
i=1
n ￿
j=1
∆i(￿ Bni − ￿ Bnj)I{ej(0;γ) ≥ ei(0;γ)}. (2.9)
Here ￿ Bni is the ith row of ￿ Bn. We note that the form of ￿ UG mimics that of the standard Gehan WLR function
UG deﬁned in Section 2.2, with the ￿ Bni taking the role of the covariates Di.
252.3.2 Approximating the Null Distribution of the Score Statistic
In the Web Appendix, we outline the derivation of the asymptotic distribution Q of n ￿ Q. This distribution
generally does not have an explicit form, so to approximate the null distribution of ￿ Q in ﬁnite samples, we
propose a perturbation approach similar to that used in Jin et al. (2003) for the linear effects AFT model.
Let V =( V1,...,Vn), and let the {Vi} be iid random variables with mean 1 and variance 1. We ﬁrst
ﬁnd ￿ γ∗
G, the minimizer of L∗
G(γ)=n−2 ￿n
i=1
￿n
j=1 ∆i|ej(0;γ) − ei(0;γ)|+ViVj. Then, we calculate the per-
turbation ￿ U∗
G(￿ γ∗
G) of ￿ UG(￿ γG) as:
￿ U∗
G(￿ γ∗
G)=n−2
n ￿
i=1
n ￿
j=1
∆i(￿ Bni − ￿ Bnj)I{ej(0;￿ γ∗
G) ≥ ei(0;￿ γ∗
G)}ViVj. (2.10)
Using similar arguments as Jin et al. (2001), we can show that under H0, the distribution of n
1
2 ￿ UG(￿ γG) can
be approximated by the distribution of n
1
2{￿ U∗
G(￿ γ∗
G)− ￿ UG(￿ γG)} conditional on O. Thus, the null distribution
of ￿ Q can be approximated by the distribution of ￿ Q∗ = ￿ Q∗(￿ γ∗
G)={￿ U∗
G(￿ γ∗
G)− ￿ UG(￿ γG)}
T{￿ U∗
G(￿ γ∗
G)− ￿ UG(￿ γG)}
given O.
To calculate a p-value for testing H0, we may generate a large number of realizations of V, say
V(1),...,V(B), and use them to generate ￿ Q∗
(1),..., ￿ Q∗
(B) Then the p-value of the test can be obtained by
￿ p =# { ￿ Q∗
(b) ≥ ￿ Q}/B. Alternatively, we may use the Satterthwaite method to approximate the null distribu-
tion using a scaled χ2 distribution, c0χ2
d0. We estimate c0 and d0 by matching moments with the estimated
null { ￿ Q∗
(b)}, and calculate ￿ pχ2 =1− F( ￿ Q), where F is the distribution function of a ￿ c0χ2
￿ d0 random variable.
Similar approximations have performed well for other models (Liu et al., 2007, 2008; Cai et al., 2011).
For the linear kernel, which does not rely on an additional parameter ρ, we may use the p-values
￿ pobs = ￿ p or ￿ pχ2,obs = ￿ pχ2 directly. For the quadratic and Gaussian kernels, the test statistic ￿ Qobs may depend
on the parameter ρ. Since the kernel matrix K(ρ) drops out of the model under the null, the parameter ρ is
not estimable (Davies, 1987). Instead, we propose to use as a test statistic:
￿ TI =i n f
ρ∈I
￿
￿ pχ2(ρ)
￿
, (2.11)
where ￿ pχ2(ρ) denotes the p-value from the χ2 approximation derived under kernel function K(·,·;ρ) and
I is an appropriately chosen range for ρ. The ﬁnal p-value then is ￿ pobs =# {￿ T∗
I,(b) ≤ ￿ TI,obs}/B. For the
Gaussian and quadratic kernels, we determine the range I of ρ by requiring that the associated kernel
matrices K(ρ) have eigenvalues ￿ λi that decay at a polynomial rate O(i−α) for some range of α > 1. This
approach is motivated by work in Braun (2005) which bounds the error due to projecting the feature space
26onto the ﬁrst r principal components using terms whose behavior depends on the decay properties of the
eigenvalues. By experimentation we found that α ∈ [1.75,6] yielded a reasonable range of feature space
complexity. To implement this, for each ρ, we regressed the logarithms of the top 95% of eigenvalues
on their indices and used the regression coefﬁcient as an estimate of α; we considered values ρ whose
associated α fell in the speciﬁed range.
2.3.3 Estimation and the Kernel Principal Components Analysis Approximation
To construct a risk score γ
TD + h(Z) for predicting T, we can minimize the penalized Gehan objective
function (2.6) to get estimates for γ and α. The parameter c in (2.6) controls the smoothness of the resulting
estimator for h, and can be chosen by cross-validation to minimize, for example, the unpenalized Gehan
objective function. For kernels that depend on a tuning parameter ρ, we use the value of ρ that minimized
￿ TI in (2.11). This choice is intuitively appealing because this ρ corresponds to the kernel K(·,·;ρ) that
produced the most evidence that h(·) ￿=0 .
While estimating (γ,α) in this manner is possible, it can be extremely computationally demanding
because the dual parameter vector α has n components. Computation time can be decreased with little
loss of accuracy by using a kernel PCA approximation for dimension reduction (Sch¨ olkopf et al., 1998;
Mika et al., 1999). To do this, we again employ the spectral decomposition of K, but retain only the ﬁrst
r principal components, where r is the smallest number for which
￿r
i=1 ￿ λi/
￿n
i=1 ￿ λi ≥ p, where p is some
prespeciﬁed fraction. In many situations, r is signiﬁcantly smaller than n. Ideally, the included eigenvectors
encode aspects of maximal variability in the data, while the excluded eigenvectors capture noise.
Writing ￿ Br =
￿￿
￿ λ1￿ ζ1 ···
￿
￿ λr￿ ζr
￿
and ￿ Kr = ￿ Br￿ B
T
r, we may consider an approximate working model
analogous to (2.7) with ￿ Kr in place of K. In fact, our pseudo-score test may be derived exactly as above with
￿ Kr and ￿ Br in place of K and ￿ Bn to yield a slightly faster test procedure, which is what we use in practice.
For estimation, we may apply the variable transformation β = ￿ B
T
rα and rewrite the working model as:
logT = Dγ + ￿ Brβ + E,E (β)=0 , Var(β)=τ2Ir×r. (2.12)
Then, instead of estimating (γ,α), we estimate (γ,β) by minimizing
LR
G(β,γ)=n−2
n ￿
i=1
n ￿
j=1
∆i|￿ ej(β;γ) − ￿ ei(β;γ)|+ +
c2
2
β
Tβ. (2.13)
where ￿ ei(β;γ) = logXi − γ
TDi − β
T￿ Bri, for ￿ Bri the ith row of ￿ Br. The parameter β has r components, so
27when the sample size is not small and the eigenvalues decay quickly, kernel PCA has the computational
advantage of greatly reducing the number of unknown parameters to be estimated.
Formulating the estimation of h in this way is also appealing because it relates to the primal repre-
sentation of h in the Hilbert space HK. The space HK has a (possibly inﬁnite) basis {
√
λlζl(·),l=1 ,2,...}
made up of eigenfunctions and eigenvalues ζl(·) and λl of the integral transform T : HK → HK deﬁned
by [Tf](z)=
￿
K(z,z￿)f(z￿)dz￿, where λ1 ≥ λ2 ≥ ···. Any function h ∈ HK may be written in its primal
representation, h(z)=
￿∞
l=1 βl
√
λlζl(z), and if the eigenvalues decay quickly, can be well-approximated
by a truncated sum hr0(z)=
￿r0
l=1 βl
√
λlζl(z) for some sufﬁciently large r0. It has been shown that the
eigenvalues and eigenvectors obtained based on K can be used to consistently estimate the underlying
true eigenvalues and eigenfunctions (Koltchinskii and Gin´ e, 2000; Braun, 2005). Thus, kernel PCA uses the
eigendecomposition of K to approximate the basis of HK, and uses that to estimate h in its approximate
primal form.
To apply the risk score to a future subject with predictors W0 =( D
T
0,Z
T
0)
T, we may use the Nystr¨ om
approximation method (Rasmussen and Williams, 2006) which relates these predictors to those in the train-
ing data. Letting (￿ γ
T, ￿ β
T) be the estimators for (γ
T,β
T), the risk score for the future subject is
D
T
0￿ γ +
r ￿
l=1
￿ βlK
T
Z0
￿ ζl￿ λ
− 1
2
l ,
where KZ0 =( K(Z0,Z1),...,K(Z0,Zn))
T.
2.4 General WLR and Kernel Selection
2.4.1 Testing and Prediction with General Weights
Although parameter estimates using the Gehan-weighted WLR are consistent, their performance in ﬁnite
samples will vary depending on the underlying distributions of survival and censoring. To optimize the
power of our pathway test and the accuracy of our risk prediction for a given dataset, it is desirable to
extend these procedures to incorporate a general weight φ(β;γ,t). Since the WLR does not in general cor-
respond to an objective function, we follow the same iterative strategy as proposed in Jin et al. (2003) to
derive estimation and testing procedures for a general weight.
We ﬁrst discuss estimation, using the computationally convenient kernel PCA approximation which
uses a pre-speciﬁed proportion p of the eigenvalues; results corresponding to the original kernel can be
28obtained by setting p =1 . We initialize {￿ γ(0), ￿ β(0)} = {￿ γG, ￿ βG}, which are estimated using the Gehan
weights as described in Section 2.3.3. Then at step k, from given estimates {￿ γ(k−1), ￿ β(k−1)}, we may obtain
an updated estimator {￿ γ(k), ￿ β(k)} as the minimizer of
￿ LR
φ(β;γ)=n−2
n ￿
i=1
n ￿
j=1
ψ(￿ β(k−1);￿ γ(k−1),e i(￿ β(k−1);￿ γ(k−1)))∆i|￿ ej(β;γ) − ￿ ei(β;γ)|+ +
c2
k
2
β
Tβ (2.14)
where the ck are a sequence of regularizing constants which converge to some c, and ψ(β;γ,t)=
φ(β;γ,t)/S(0)(β;γ,t) for
S(k)(β;γ,t)=n−1
n ￿
j=1
I{ej(β;γ) ≥ t}
￿
Dj
￿ Brj
￿⊗k
.
As k →∞ , {￿ γ(k), ￿ β(k)} converges to {￿ γφ, ￿ βφ}, a solution to ￿ Uφ(β;γ)+c2β =0 , where
￿ Uφ(β;γ)=n−1
n ￿
i=1
φ(β;γ,e i(β;γ))∆i
￿￿
Di
￿ Bri
￿
−
S(1)(β;γ,e i(β;γ))
S(0)(β;γ,e i(β;γ))
￿
.
For testing with a general weight, we may derive the score test using the same arguments as in Section
2.3 but add weights ψ(￿ β(k−1);￿ γ(k−1),e i(￿ β(k−1);￿ γ(k−1))) to (2.9), where {￿ γ(k−1), ￿ β(k−1)} are some initial esti-
mates of {γ,β}. When testing H0 : h(·)=0 , it is convenient to set ￿ β(k−1) =0 , its value under the null, and
let ￿ γ(k−1) = ￿ γφ, the WLR estimator under H0 which can be found using the iterative method in Jin et al.
(2003). With these choices, no iteration is needed to calculate the test statistic after ￿ γφ has been found. Our
WLR KM test statistic for a general weight φ is thus ￿ Qφ = ￿ Uφ(￿ γφ)
T ￿ Uφ(￿ γφ) where
￿ Uφ(γ)=n−2
n ￿
i=1
n ￿
j=1
ψ(0;γ,e i(0;γ))∆i(￿ Bni − ￿ Bnj)I{ej(0;γ) ≥ ei(0;γ)}.
Perturbations used to approximate the null take the form ￿ Q∗
φ =( ￿ U∗
φ(￿ γ∗
φ) − ￿ Uφ(￿ γφ))
T(￿ U∗
φ(￿ γ∗
φ) − ￿ Uφ(￿ γφ))
where ￿ γ∗
φ is a perturbation of ￿ γφ under H0 associated with a particular realization of V, and where:
￿ U∗
φ(γ)=n−2
n ￿
i=1
n ￿
j=1
ψ∗(0;γ,e i(0;γ))∆i(￿ Bni − ￿ Bnj)I{ej(0;γ) ≥ ei(0;γ)}ViVj.
with ψ∗(0;γ,t)=1 /S(0)∗(0;γ,t) for S(0)∗(0;γ,t)=n−1 ￿n
j=1 I{ej(0;γ) ≥ t}V j. When φ =1 , ￿ Qφ reduces
to the KM score statistic proposed in Cai et al. (2011) in the absence of clinical covariates.
2.4.2 Combining P-Values Across Models and Kernels
In practice, little prior information is available on the optimal choices of the kernel or WLR weights for a
given dataset. Hence, data-driven methods to combine information from multiple weights and kernels are
29desirable. To this end, we propose a test statistic ￿ A which combines the test statistics for several weight-
kernel combinations of interest. To generate the null distribution of ￿ A, we use a common collection of
realizations {V(1),...,V(B)} of the n-vector V =( V1,...,Vn) of iid mean-1 variance-1 random variables Vi
to generate null distributions of each weight-kernel combination of interest, thus obtaining their joint null
distribution. We can then generate the null distribution of ￿ A by calculating its value, ￿ A∗
(b), associated with
eachV(b),andgenerateaP-valuebycomparing ￿ Aobs to{ ￿ A∗
(1),..., ￿ A∗
(B)}–i.e., ￿ pcombined =# { ￿ A∗
(b) ≥ ￿ Aobs}/B.
We propose to use the method developed in Xu et al. (2003) for combining dependent tests. This
method ﬁrst transforms the P-values into z-scores by Zk = Φ−1(1 − pk), yielding a vector of observed z-
scores Zobs and its associated null {Z∗
(1),...,Z∗
(B)}. The Z∗
(b) are used to estimate Γ, the covariance of Z, and
thenthefunctionW(c)=Z
T
cΓ−1Ziscomputedforc ∈ [0,4], whereZc isavectorwithentriesmax{Zk,c}.By
calculating W(c) for both the observed Zobs and the null Z∗
(b), an estimated P-value pXu(c) can be calculated
for each c, and the ﬁnal test statistic whose value on the observed data is compared to its value on the null
is ￿ AXu =m i n c∈[0,4] pXu(c).
As in testing, the best choice of kernel and weight for risk prediction may not be obvious. We consider
two automated approaches for determining which kernel-weight combination to use for the estimation
of h. In the ﬁrst approach, we apply the associated KM tests to the pathway and use the kernel-weight
pair which yields the smallest p-value. In the second approach, we choose the kernel-weight pair which
optimizes prediction accuracy. Speciﬁcally, for each pair, we estimate a C-statistic which captures how well
the order of the associated risk predictions corresponds to the order of the true survival times Ti during a
pre-speciﬁed follow-up period (0,τ),C τ = P(￿ γ
TDi + ￿ h(Zi) > ￿ γ
TDj + ￿ h(Zj)|Ti >T j,T j < τ). We estimate
Cτ in the presence of censoring using the nonparametric estimator proposed in Uno et al. (2011), and select
the kernel-weight combination which yields the largest value of Cτ.
2.5 Simulation Studies
2.5.1 Testing
We conducted simulation studies to assess the performance of the proposed testing and estimation proce-
dures. We generated the pathway covariates Z from a multivariate normal distribution with mean 0 and
compound symmetry covariance structure with variance 1 and correlation ℘. We considered pathways of
30size P =5and 20, and correlations ℘ =0 .8,0.5 and 0.2 to represent strong, moderate, and weak within-
pathway correlation. For simplicity we did not include any additional covariates. We simulated different
types of underlying signals h(z) to understand the performance of our procedures in different settings. For
a given h(z), we generated survival times according to the model logT = h(Z)+E. We compared two
different types of error distributions, generating E from either the extreme value distribution (EVD) or a lo-
gistic distribution Logistic(µ,σ), where µ and σ were chosen so that the survival times resulting from both
choices of E were of comparable magnitude. The censoring was generated from a uniform distribution
with range chosen so that approximately 25% of the individuals were censored.
To assess the performance of the testing procedures in each setting, we simulated 2000 data sets for
empirical size calculations and 1000 for empirical power, and compared the AFT KM pseudo-score tests
with Gehan weights (WLRGe) and log-rank weights (WLRLR) for the Gaussian, quadratic, and linear ker-
nels. We note that the WLRLR test statistic is the same as the Cox KM test statistic proposed by Cai et al.
(2011) when there are no other covariates, although the speciﬁc method used for approximating the null
distribution differs. All null distributions were generated using B = 2000 perturbations, and kernel PCA
was used to reduce dimensionality, with p =0 .95. For the linear kernel which needs no tuning, we consid-
ered the perturbation p-value ￿ p and the χ2−approximated p-value ￿ pχ2 directly. For the kernels which rely
on a tuning parameter ρ, we considered the test based on ￿ TI =i n f ρ∈I
￿
￿ pχ2(ρ)
￿
and compared two other
candidate test statistics: ￿ SI =s u p ρ∈I
￿
￿ Q(ρ)/￿ σ(ρ)
￿
and ￿ RI =i n f ρ∈I {￿ p(ρ)}, where ￿ Q(ρ), ￿ p(ρ), and ￿ pχ2(ρ)
denote respectively the test statistic, p-value from perturbation, and p-value from the χ2 approximation
derived under kernel function K(·,·;ρ); and ￿ σ(ρ) is the estimated standard error of ￿ Q(ρ) obtained from the
perturbations. The results for the different tests used for each kernel were nearly identical, so those based
on the χ2-approximations are shown in the tables. We also considered the omnibus test described in Sec-
tion 2.4.2; for comparison, we also considered three other candidates ￿ A upon which to base an omnibus test:
￿ AFisher = −2
￿K
k=1 logpk (Fisher, 1925); ￿ ATruncated = −2
￿K
k=1 I{pk ≤ 0.05}logpk (Zaykin et al., 2002); and
￿ Amin-p =m i n k {pk}. We considered combining across kernels within WLR weights, across weights within
kernel, and across all six weight-kernel combinations; for simplicity, only the p-values combined across all
six are shown in the tables.
For comparison to our KM-based tests, we also considered a method for assigning a p-value to a
pathway based on the marginal associations between the genes in the pathway and survival. For each gene
Zi,i=1 ,...,P,in the pathway, we calculated a marginal p-value ￿ p
marg
i from the Wald test from a standard
31univariate Cox model, and then calculated the minimum of these P p-values, ￿ p
marg
min =m i n {￿ p
marg
1 ,...,￿ p
marg
P }.
Weadjustedthisp-valueformultipletestingusingtheeffectivenumberoftests, Meff,asdescribedinNyholt
(2004). That is, we deﬁne ￿ p
marg
pathway =1−[1−￿ p
marg
min]Meff, where for observed eigenvalues ￿ ￿j from the covariance
matrix of the genes in the pathway, Meff =1+( P − 1)(1 − Var(￿ ￿1,...,￿ ￿P)/P).
To examine the validity of the test procedure in ﬁnite samples, we generated data under the null
setting h(z)=0 . The empirical sizes at Type I error rate of 0.05 are shown in Table 2.1 for n = 200 and 400.
When n = 200, the empirical sizes of the KM tests tend to be slightly below their nominal level, especially
when the within-pathway correlation is low. The four combined p-values maintain their nominal level. The
empirical sizes of all the tests are closer to their nominal level when the sample size is increased to n = 400.
To assess the power of the proposed tests, we considered for n = 200 (1) a linear signal, h1(z)=
c(z1 + z2 + z3 + z4 + z5) with c =0 .05, and (2) a nonlinear signal, h2(z)=c[z1 +4 z2
1 + z2 +4 z2
2 − 2z1z2 +
g(z3)(4z4 +4z5)+(1−g(z3))(−3z4 −3z5 +4z4z5)], with c =0 .75 and g(z) ∼ Bernoulli(e−|z|). This function
was chosen to have different types of nonlinear signal: the linear, quadratic, and interactive effects of z1
and z2, and the latent classes deﬁned by z3 with differential signal deﬁned by z4 and z5. Results are shown
in Table 2.2.
When the true signal is linear, one would expect the linear kernel to outperform the other kernels,
but interestingly, all three kernels yield tests with competitive power. This can in part be attributed to the
fact that both the Gaussian and quadratic kernels can capture primarily linear effects at certain values of
their tuning parameters. When the true signal is nonlinear, the linear kernel performs poorly, particularly
in the high correlation setting. In comparison, the quadratic kernel has somewhat higher power, while the
Gaussian kernel can have substantially more power. For all tests, the power decreases somewhat when
we increase the number of covariates from P =5to P = 20; however, the power loss is small when the
correlation is high due to the low effective degrees of freedom in such settings. This highlights one of
the advantages of the KM based tests – that they beneﬁt from within-pathway correlation. We do not see
substantial gains from using the quadratic kernel, either in these setting or in settings where the quadratic
effect is stronger (results not shown).
Among the four omnibus tests considered, the Xu method appears to most robustly maintain power
across different settings. Its performance is slightly weaker than the other omnibus tests when the true
signal is linear, but it still outperforms the worst choices of weight-kernel combination; however, in the
nonlinear setting, it tends to be more powerful than the other tests. In several of the nonlinear settings, its
32Table 2.1: Empirical sizes (%) at Type I error rate of 0.05 when n = 200 and n = 400. Testing was performed
using the Gaussian, linear, and quadratic kernels using both the WLRGe and WLRLR tests. For the linear
kernel, the χ2 approximated p-value is presented; for the Gaussian and quadratic kernels, the p-value based
on the χ2 minp statistic (￿ TI in the text) is presented. Results shown use kernel PCA with 95% of eigenvalues
used. Also shown are the empirical sizes of the four proposed omnibus tests – Fisher, Truncated, min-p,
and Xu – across all 6 weight-kernel combinations. Shown for comparison are results for the marginal gene
method.
Correlation 0.2 0.5 0.8
Pathway Size 5 20 5 20 5 20
Error EVD logis EVD logis EVD logis EVD logis EVD logis EVD logis
n = 200
Marginal Gene 5 5 5 5 5 5 5 5 7 6 6 6
WLRGe
Gaussian 3 3 3 3 4 3 4 3 3 4 4 4
Linear 2 2 2 2 4 3 3 3 3 3 4 4
Quadratic 3 3 3 3 4 4 4 3 3 3 3 4
WLRLR
Gaussian 3 4 4 3 4 4 5 5 4 4 5 4
Linear 3 3 2 2 4 4 4 4 4 4 4 4
Quadratic 4 4 4 3 4 4 5 5 4 4 5 4
Omnibus
Fisher 3 3 3 3 4 4 4 4 3 4 4 4
Truncated 3 3 3 2 4 4 4 3 3 4 4 4
Min-P 3 3 2 2 4 3 4 3 2 3 3 3
Xu 2 2 2 2 4 3 4 3 2 3 3 4
n = 400
Marginal Gene 5 5 5 5 6 6 6 5 6 6 5 5
WLRGe
Gaussian 4 4 4 4 5 4 6 4 5 4 4 4
Linear 3 4 3 3 5 4 5 4 4 4 4 4
Quadratic 4 4 4 4 5 5 6 5 4 4 4 4
WLRLR
Gaussian 4 5 4 5 5 5 6 5 5 5 5 4
Linear 4 4 3 4 5 4 6 4 4 5 5 4
Quadratic 4 5 4 5 5 5 6 5 5 6 6 4
Omnibus
Fisher 3 4 4 5 5 5 6 5 4 4 5 4
Truncated 3 4 4 4 5 4 6 5 4 4 5 4
Min-P 3 4 4 3 5 4 6 4 4 4 5 4
Xu 3 3 3 3 5 4 6 4 4 4 5 4
33Table 2.2: Empirical power (%) for linear and nonlinear signal at Type I error rate of 0.05 when n = 200.
Tests shown are identical to those in Table 2.1.
Correlation 0.2 0.5 0.8
Pathway Size 5 20 5 20 5 20
Error EVD logis EVD logis EVD logis EVD logis EVD logis EVD logis
linear h(z)
Marginal Gene 27 20 18 15 57 43 47 35 77 66 74 58
WLRGe
Gaussian 24 25 17 23 46 48 42 43 55 62 60 60
Linear 22 23 12 17 46 48 39 39 62 66 62 62
Quadratic 27 26 17 23 46 49 42 43 52 56 61 60
WLRLR
Gaussian 35 22 25 20 57 42 55 40 70 57 72 56
Linear 30 19 20 14 58 43 52 38 74 62 74 59
Quadratic 36 23 26 20 59 44 55 40 66 52 72 56
Omnibus
Fisher 31 25 21 20 56 48 50 42 70 66 70 63
Truncated 30 23 20 20 56 48 50 42 70 64 71 62
Min-P 30 23 19 18 52 45 49 40 63 58 68 58
Xu 25 20 16 15 51 42 48 38 64 59 66 57
nonlinear h(z)
Marginal Gene 52 54 37 40 44 48 34 37 18 19 10 10
WLRGe
Gaussian 87 88 28 30 85 87 23 25 93 92 51 50
Linear 38 38 23 26 19 19 13 16 5 5 4 4
Quadratic 39 40 27 29 32 34 14 17 67 70 37 36
WLRLR
Gaussian 94 95 41 44 98 99 48 46 100 100 94 94
Linear 47 49 34 38 31 32 25 26 4 5 4 5
Quadratic 50 51 38 41 52 55 29 30 95 95 73 73
Omnibus
Fisher 67 69 32 36 62 65 25 27 90 90 44 44
Truncated 71 74 33 37 73 72 27 28 97 95 56 57
Min-P 92 92 33 36 96 97 40 39 100 99 86 85
Xu 98 98 33 36 100 99 66 68 100 100 98 97
34power is greater than all individual weight-kernel tests, suggesting it is gaining power when several tests
have nearly signiﬁcant results. This points to the robustness of the omnibus test, which could make it useful
in a wide range of settings.
2.5.2 Estimation
To assess the performance of the estimation procedure when the true signal is linear (h1 from above, with
c =0 .4) or nonlinear (h2 with c =3 ), we ran 500 simulations in the same conﬁgurations of correlations,
pathway sizes, and error distributions. Each simulation consisted of two data sets: a training data set with
sample size ntrain = 100 on which to build the estimates ￿ h, and a validation data set with sample size
ntest = 1000 on which to assess how well each estimate predicted survival up until some time t0 using the
C-statistic (Uno et al., 2011). In these simulations, we selected a reference time t0 that was near the 70th
percentile of followup time.
Using the training data, we built estimators for the Gehan and LR weights using linear, quadratic,
and Gaussian kernels. We also ﬁt standard full Cox and AFT models for comparison. We applied these
estimators and models to the validation data and calculated the C-statistic. We considered two methods
for choosing which kernel to use in the ﬁnal estimate ￿ h; in one, we choose the kernel with the smallest p-
value from the pseudo-score test in the training data; in the other, we choose the kernel yielding the largest
estimated C-statistic in the training data. Results are presented in Table 2.3.
In the linear setting, the C-statistics are nearly identical across all models. In the nonlinear setting, we
see huge gains over the full model by using nonlinear kernel functions. In this setting, the predictive ability
of the three kernels varies more, so it is more meaningful to select a kernel. The model using the kernel
selected using the C-statistic has almost uniformly better predictive ability than all other models, and thus,
we recommend selecting kernel based on the estimated C-statistic.
2.6 Example: Breast Cancer Gene Expression Study
Genomic information has already improved our understanding of breast cancer. The mutations found
in the BRCA1 and BRCA2 genes identify women at high risk of developing breast cancer (Narod and
Foulkes, 2004), and a number of gene expression signatures have been introduced into clinical practice to
better identify cancers with high and low risk of recurrence (Desmedt et al., 2011). Despite these advances,
35Table 2.3: Empirical C-statistic (%) for predicting survival up to time t0 for linear and nonlinear signal,
where t0 is approximately the 70th percentile of follow-up time. ￿ h(z) is built in a training data set with
ntrain = 100; results shown use kernel PCA with 95% of eigenvalues used. All C-statistics are calculated by
applying ￿ h(z) to a testing data set with ntest = 1000. For kernel methods, we present the C-statistic for ￿ h
estimated from each of the three kernels, and the C-statistic if we select kernel based on KM test p-value
P, or ￿ C, the estimated C-statistic in the training data. For comparison, we present the Cox and AFT full
models, which are the models ﬁt with all pathway variables as linear covariates.
Correlation 0.2 0.5 0.8
Pathway Size 5 20 5 20 5 20
Error EVD Exp EVD Exp EVD Exp EVD Exp EVD Exp EVD Exp
linear h(z)
Full
AFT-G 76 75 73 74 79 79 76 77 82 83 79 78
AFT-LR 77 75 74 73 79 79 77 77 82 83 80 79
Cox 77 75 74 73 79 79 77 77 82 82 80 79
WLRGe Kernel
Gaussian 77 75 73 73 79 79 78 78 82 82 82 81
Linear 77 75 74 74 80 79 78 79 82 83 82 81
Quadratic 77 75 73 73 79 79 77 78 82 83 82 81
WLRLR Kernel
Gaussian 77 75 73 73 79 79 78 78 82 82 82 81
Linear 77 75 75 74 80 79 78 79 82 83 83 81
Quadratic 77 75 73 73 80 79 78 78 82 83 83 81
Omnibus P 77 75 75 74 79 79 78 79 82 83 82 81
Omnibus C 77 75 74 74 79 79 78 79 82 83 82 81
nonlinear h(z)
Full
AFT-G 55 55 52 53 54 53 53 53 55 55 53 53
AFT-LR 55 55 52 53 54 54 53 53 55 55 53 53
Cox 55 55 52 53 54 54 53 53 55 55 53 53
WLRGe Kernel
Gaussian 66 68 52 53 65 65 53 54 67 67 60 61
Linear 55 55 52 53 54 53 52 52 53 52 51 51
Quadratic 56 56 52 53 59 59 53 54 62 61 57 58
WLRLR Kernel
Gaussian 66 69 53 54 66 66 55 56 67 69 63 63
Linear 55 55 52 53 54 54 52 53 53 53 51 51
Quadratic 56 57 52 53 60 60 54 55 62 63 59 60
Omnibus P 66 68 53 54 66 65 55 55 66 68 61 62
Omnibus C 67 69 53 54 67 67 55 56 68 68 62 62
36approximately 60% of patients with early-stage breast cancer are given adjuvant therapy in addition to
local treatment, while only a small proportion are thought to beneﬁt (Reis-Filho and Pusztai, 2011). Better
markers of aggressive disease would help physicians predict which patients could safely avoid adjuvant
therapy and its negative side-effects, and which patients should be treated with more aggressive therapy.
One promising hypothesis-driven approach is to investigate the effects of candidate pathways on pa-
tient survival. We examine the associations between recurrence-free survival and 32 candidate pathways
from the molecular signature database. We consider, for example, the p53 pathway because mutation of
p53 has been previously found to be associated with more aggressive disease and worse overall survival in
breast cancer (Gasco et al., 2002).
To assess the effects of these pathways on breast cancer progression, we applied our pseudo-score test
to each of the pathways in a training set of 286 lymph node negative breast cancer patients who received no
systemic adjuvant therapy (Wang et al., 2005). We used tumor gene expression assessed on the Affymetrix
U133a Gene Chip, and controlled for ER status. A total of 107 deaths or recurrences were observed, with
follow-up time ranging between 2 months and 14.3 years (median 7.2 years); 63% of observations were
censored. Figure 2.1 shows the results of the testing procedure. For each pathway, we compare the p-value
from the marginal-gene based method to the p-value for the Xu omnibus test combining KM tests for all
six weight-kernel combinations. 20 pathways were signiﬁcant at the nominal 0.05 level using the marginal
gene method, and 22 were signiﬁcant using the omnibus test.
Since multiple pathways are under consideration, we need to adjust for multiple comparisons. To
adjust the marginal gene-based p-value we may use the same ￿ p
marg
pathway deﬁned in Section 2.5.1, but with the
effective degrees of freedom Meff calculated using all the genes in the pathways under consideration. To
adjust the KM-based p-value, we may use the approximate null distribution generated by perturbation to
get the null distribution of the minimal p-value across the 32 pathway tests under the null, and compare
the observed pathway p-values to this null distribution. After adjustment, one pathway is still signiﬁcant
using the marginal gene method, while 5 remain signiﬁcant using the omnibus KM test.
For each of the ﬁve pathways declared most signiﬁcant by our KM test, we estimated the pathway
effect on recurrence-free survival in the training set using the kernel which optimized the C-statistic; for
comparison, we also ﬁt a standard Cox model. We applied these estimates to an independent validation
set of 119 lymph node negative patients with no adjuvant therapy, with gene expression assessed on the
same chip (Sotiriou et al., 2006). In this validation set, 27 deaths or recurrences were observed, with follow-
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Figure 2.1: log10 p-values for testing the overall effect of 32 pathways on breast cancer survival. Black
squaresrepresentthepathwayp-valuesfromthemarginal-geneapproach, andthepathwaysareorderedby
this p-value. Diamonds represent the Xu combined KM p-values. The left hand panel shows the unadjusted
p-values, while the right hand panel shows the p-values adjusted for multiple testing. Results are based on
B = 5000 perturbations.
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Figure 2.2: Point estimates and conﬁdence intervals for the C-statistics for a full standard Cox model (Cox)
and our KM model (KM) for the 5 pathways with lowest KM p-value. Models were built on training
data (n = 286) and applied to testing data (n = 119), where the C-statistics and conﬁdence intervals were
estimated.
39up time ranging between 2 months and 14.5 years (median 7.7 years); 77% of observations were censored.
We assessed the accuracy of each model using the C-statistic and calculated 95% conﬁdence intervals (Uno
et al., 2011). The conﬁdence intervals for the C-statistics for the Cox model ﬁt to each pathway crossed 50%,
while three of the pathways had KM conﬁdence intervals which did not cross 50%, suggesting potential for
improvement in risk prediction using AFT KM modeling.
2.7 Discussion
In this paper, we proposed KM based procedures to test for the effect of pathways on survival in an AFT
model framework. By taking a pathway based approach, we take advantage of pre-existing biological
knowledge and privilege groups of genes believed to work together. By working with both linear and
nonlinear kernels, we can detect linear effects well, while improving power to detect nonlinear effects when
compared to methods based on linearity assumptions. When interest lies in risk prediction, our proposed
risk scores from the AFT KM framework may be easily used for risk assessment. These risk scores have the
potential to capture nonlinear effects which can improve over methods assuming linearity, as demonstrated
in simulation. They also gain strength from within-pathway correlation, which is likely to exist in gene
expression data.
In analysis of real data, it is unlikely that the researcher knows which weight or kernel is most ap-
propriate for his or her data set. Thus, we have proposed omnibus testing and estimation procedures that
allow the data to drive weight and kernel choice. The perturbation procedures used to generate the null
distributions for our AFT KM tests enable us to efﬁciently combine information across kernels and weights.
Based on simulation results for testing, the power lost is often minimal, but the power gained over the
worst choice can be quite large. Moreover, for risk prediction, it appears that the omnibus estimation pro-
cedure has negligible loss in prediction accuracy when compared to the optimal kernel. Our perturbation
procedures also allow for straightforward control of multiple testing that is not overly stringent when there
is between-pathway correlation.
When the underlying signal is sparse with only a few genes in a pathway associated with survival, it
would also be interesting to extend our proposed procedure to allow for feature selection under the KM
framework. We were motivated to develop these kernel machine methods for the AFT model because of
an attractive property of linear models that when two groups of covariates are independent, their marginal
40effects on outcome are equal to their joint effects. In the context of gene-sets, this would mean that if we
are considering high-dimensional genetic data which we can divide into a large number of independent
pathways, we may assess the effect of each pathway individually, and then combine their marginal effects
additively into a joint model. Future work will explore this application to large data sets, and investigate
our abilities to combine information across both independent and correlated pathways.
2.8 Appendix: Asymptotic Distribution of the Test Statistic
Here we derive the asymptotic null distribution of our test statistic. Throughout, we assume that the co-
variates Di and the genomic marker values Zi are bounded by a constant zm. We assume that the true
value of γ, γ0, is an interior point of a compact set Ω, and without loss of generality, we also assume that X
has a ﬁnite support [0,τ]. For ease of notation, unless otherwise noted, the supremum is always taken over
(−∞,log(τ)] for the index t, [−zm,zm] for Z and Ω for γ. We also require the same set of assumptions given
in Jin et al. (2003) for the iterative WLR estimation procedures. For simplicity, we focus on the Gehan weight
but note that similar arguments can be used for the general weight. From Jin et al. (2001, 2003), we have
n
1
2(￿ γ−γ0)=n− 1
2
￿n
i=1 Uγi+op(1) for some independent and identically distributed random variables Uγi,
where ￿ γ = ￿ γG in the text. We will derive the null distribution of ￿ Q(￿ γ;ρ) and demonstrate its convergence
as a process in ρ. The kernel function K is assumed to be continuously differentiable and the regularity
conditions required in Braun (2005) are assumed to hold for the convergence of the empirical eigenvalues
and eigenfunctions of HK. Under these regularity conditions, the convergence of the null distribution of
￿ Q(￿ γ;ρ), the test statistic with kernel PCA, can be derived using the convergence of ￿ K to the kernel matrix
corresponding to a truncated kernel, which spans HKr0 = span{
√
λ1ζ1(·),...,
￿
λr0ζr0(·)}(Braun, 2005).
The test statistic takes the form ￿ Q(￿ γ,ρ)=￿ R(￿ γ)
TK(ρ)￿ R(￿ γ), where ￿ R(γ)=(￿ R1(γ),...,￿ Rn(γ))
T,
￿ Ri(γ)=n−2
n ￿
j=1
￿￿
Yj(t;γ)dNi(t;γ) −
￿
Yi(t;γ)dNj(t;γ)
￿
,
Ni(t;γ)=∆iI[ei(0;γ) ≤ t] and Yi(t;γ)=I[ei(0;γ) ≥ t]. We can write n ￿ Q(￿ γ,ρ) as:
n ￿ Q(￿ γ,ρ)=n
n ￿
i=1
n ￿
j=1
K(Zi,Zj;ρ)￿ Ri(￿ γ)￿ Rj(￿ γ)
=
￿￿
K(u,v;ρ)d
￿√
n ￿ WR(u;￿ γ)
￿
d
￿√
n ￿ WR(v;￿ γ)
￿
.
41where ￿ WR(u;￿ γ)=
n ￿
i=1
I[Zi ≤ u]￿ Ri(￿ γ).
= n−2
n ￿
i=1
n ￿
j=1
I[Zi ≤ u]
￿￿
Yj(t;￿ γ)dNi(t;￿ γ) −
￿
Yi(t;￿ γ)dNj(t;￿ γ)
￿
=
￿
￿ π(zm,t;￿ γ)￿ WN(u,dt;￿ γ) −
￿
￿ π(u,t;￿ γ)￿ WN(zm,dt;￿ γ),
￿ π(u,t;γ)=n−1
n ￿
i=1
I[Zi ≤ u]Yi(t;γ), ￿ WN(u,t;γ)=n−1
n ￿
i=1
I[Zi ≤ u]Ni(t;γ),
and I(Zi ≤ u)=I(Zi1 ≤ u1,...,Z ip ≤ up). Let π(u,t;γ)=E [I[Z ≤ u]Y (t;γ)],µ (u,t;γ)=
E [I[Z ≤ u]N(t,γ)], ￿ WN(u,t;γ)=￿ WN(u,t;γ) − µ(u,t;γ), and ￿ Wπ(u,t;γ)=￿ π(u,t;γ) − π(u,t;γ). Then
we can expand
√
n ￿ WR(u;￿ γ) as:
￿
￿ Wπ(zm,t;￿ γ)
￿√
n ￿ WN(u,dt;￿ γ)
￿
−
￿
￿ Wπ(u,t;￿ γ)
￿√
n ￿ WN(zm,dt;￿ γ)
￿
(2.15)
+
￿
π(zm,t;￿ γ)
￿√
n ￿ WN(u,dt;￿ γ)
￿
−
￿
π(u,t;￿ γ)
￿√
n ￿ WN(zm,dt;￿ γ)
￿
(2.16)
+
￿ ￿√
n ￿ Wπ(zm,t;￿ γ)
￿
µ(u,dt;￿ γ) −
￿ ￿√
n ￿ Wπ(u,t;￿ γ)
￿
µ(zm,dt;￿ γ) (2.17)
+
√
n
￿￿
π(zm,t;￿ γ)µ(u,dt;￿ γ) −
￿
π(u,t;￿ γ)µ(zm,dt;￿ γ)
￿
(2.18)
We ﬁrst show that the ﬁrst pair of integrals (2.15) is op(1). To this end, we note that by a functional central
limit theorem (FCLT) (Pollard, 1990),
√
n ￿ WN(u,t,γ) converges weakly to a Gaussian process in (u,t,γ),
denoted by WN(u,t;γ). It follows that
√
n ￿ WN(u,t;￿ γ)=
√
n ￿ WN(u,t,γ0)+op(1) (2.19)
by stochastic equicontinuity. On the other hand, by a uniform law of large numbers (ULLN) (Pollard, 1990),
supu,t,γ |￿ Wπ(u,t;γ)| = op(1) which implies that supu,t |￿ Wπ(u,t;￿ γ)| = op(1). This, together with Lemma A.3
of Bilias et al. (1997) and the strong representation theorem, implies that (2.15) = op(1) uniformly in u.
The integrals in (2.16) have the same limiting distribution as
￿
π(zm,t;γ0)
￿√
n ￿ WN(u,dt;γ0)
￿
−
￿
π(u,t;γ0)
￿√
n ￿ WN(zm,dt;γ0)
￿
.
We may see this by adding and subtracting π(u,t;γ0) to and from the integrands π(u,t;￿ γ), and us-
ing the fact that π(u,t;￿ γ) − π(u,t;γ0)
P → 0, and by using (2.19) to replace the integrating functions by
√
n ￿ WN(u,dt;γ0).
The integrals in (2.17) have the same limiting distribution as
￿ ￿√
n ￿ Wπ(zm,t;γ0)
￿
µ(u,dt;γ0) −
￿ ￿√
n ￿ Wπ(u,t;γ0)
￿
µ(zm,dt;γ0)
42To see this, note that a FCLT implies that
√
n ￿ Wπ(u,t,γ) converges weakly to a zero-mean Gaussian process
Wπ(u,t,γ). Hence,
√
n￿ Wπ(u,t;￿ γ)=
√
n￿ Wπ(u,t;γ0)+op(1), which allows us to replace the integrands
√
n￿ Wπ(u,t;￿ γ) by
√
n￿ Wπ(u,t;γ0). Further, we can expand
￿ ￿√
n ￿ Wπ(u1,t;γ0)
￿
µ(u2,dt;￿ γ)=
￿ ￿√
n ￿ Wπ(u1,t;γ0)
￿
µ(u2,dt;γ0) (2.20)
+
￿ ￿√
n ￿ Wπ(u1,t;γ0)
￿
{µ(u2,dt;￿ γ) − µ(u2,dt;γ0)} (2.21)
and see that (2.21) = op(1) by another application of Lemma A.3 of Bilias et al. (1997) and the strong
representation theorem, because µ(u,dt;￿ γ) − µ(u,dt;γ0)
P → 0.
Finally, we can write (2.18) as:
√
n
￿ ￿
π(zm,t;γ0)µ(u,dt;γ0) −
￿
π(u,t;γ0)µ(zm,dt;γ0) (2.22)
+
￿
π(zm,t;￿ γ){µ(u,dt;￿ γ) − µ(u,dt;γ0)} (2.23)
+
￿
{π(zm,t;￿ γ) − π(zm,t;γ0)}µ(u,dt;γ0) (2.24)
−
￿
π(u,t;￿ γ){µ(zm,dt;￿ γ) − µ(zm,dt;γ0)} (2.25)
−
￿
{π(u,t;￿ γ) − π(u,t;γ0)}µ(zm,dt;γ0)
￿
(2.26)
The ﬁrst line (2.22) is identically 0 because
￿
I[Z ≤ u]Y (s;γ0)λ0(s)ds is the compensator of I[Z ≤ u]N(s;γ0),
where λ0(s) is the common hazard function of Ei so that line (2.22) is exactly:
￿
E [Y (s;γ0)]E [I[Z ≤ u]Y (s;γ0)]λ0(s)ds −
￿
E [I[Z ≤ u]Y (s;γ0)]E [Y (s;γ0)]λ0(s)ds =0 .
Then, it follows from a Taylor series expansion and the expansion of n
1
2(￿ γ − γ0),
(2.18) =
√
n(￿ γ − γ0)
TA + op(1) = n− 1
2
n ￿
i=1
A
TUγi + op(1),
where A =
￿
π(zm,t;γ0)˙ µ(zm,dt,γ0)+
￿
˙ π(zm,t,γ0)µ(u,dt;γ0) −
￿
π(u,t;γ0)˙ µ(zm,dt,γ0) −
￿
˙ π(u,t,γ0)µ(zm,dt;γ0), ˙ µ(z,t,γ)=∂µ(z,t,γ)/∂γ and ˙ π(z,t,γ)=∂π(z,t,γ)/∂γ.
Putting all the aforementioned expansions together, we have
√
n ￿ WR(u;￿ γ) asymptotically equivalent
to
¯ W(u)=
√
n
￿ ￿
π(zm,t;γ0)￿ WN(u,dt;γ0) − π(u,t;γ0)￿ WN(zm,dt;γ0)
+ ￿ Wπ(zm,t;γ0)µ(u,dt;γ0) − ￿ Wπ(u,t;γ0)µ(zm,dt;γ0)
￿
+ n− 1
2
n ￿
i=1
A
TUγi.
43It then follows from another application of FCLT that ¯ W(u) converges weakly to a zero mean Gaussian
process W(u). This together with the smoothness of K, implies that n ￿ Q(￿ γ,ρ) converges weakly as a process
to
Q(ρ)=
￿￿
K(u,v;ρ)dWR(u)dWR(v).
44Pathway Selection and Aggregation using Multiple Kernel Learning
for Risk Prediction
Jennifer A. Sinnott and Tianxi Cai
Department of Biostatistics
Harvard School of Public Health
45Abstract
Attempts to predict risk using high dimensional genomic data can be made difﬁcult by the large number
of features and the potential complexity of the relationship between features and the outcome. Integrating
prior biological knowledge into risk prediction with such data by grouping genomic features into pathways
and networks reduces the dimensionality of the problem and could improve models by making them more
biologically grounded and interpretable. Pathways could have complex signals, so our approach to model
pathway effects should allow for this complexity. The kernel machine framework has been proposed to
model pathway effects because it allows for nonlinear relationships within pathways; it has been used to
make predictions for various types of outcomes from individual pathways (Scholkopf and Smola, 2002;
Liu et al., 2007, 2008; Li and Luan, 2003; Cai et al., 2011; Liu et al., 2010). When multiple pathways are
under consideration, we propose a multiple kernel learning approach to select important pathways and
efﬁciently combine information across pathways. We derive our approach for a general survival modeling
framework with a convex objective function, and illustrate its application under the Cox proportional haz-
ards and accelerated failure time (AFT) models. Numerical studies with the AFT model demonstrate that
this approach performs well in predicting risk. The methods are illustrated with an application to breast
cancer data.
463.1 Introduction
Studies relating disease outcomes to large-scale genomic data are rich resources for improving both our
understanding of the progression of disease and our ability to predict patient prognosis. However, such
studies usually have many more genomic covariates than study participants which can make it hard to
differentiate true biological relationships from noise and false positive associations. Many different ap-
proaches for solving this problem have been proposed. Some approaches focus on screening out unimpor-
tant markers (e.g., Zhao and Li, 2011) while others build models with penalized coefﬁcients (e.g., Zhang
and Lu, 2007). Such single-gene-based approaches, which allow genes to enter or leave a model individu-
ally, produce lists of important genes which can be difﬁcult to interpret or replicate. An alternative strategy
is to ﬁrst group genes into biologically relevant sets such as pathways or networks, and relate the overall
pathway effects to survival. Pathway-based methods can improve interpretability because the pathways
aredeﬁnedbyknownorhypothesizedfunctions, whichcanfacilitategenerationofmechanistichypotheses.
Moreover, they reduce dimensionality because the number of pathways is generally much smaller than the
number of genes. A number of test-based pathway methods are designed to identify important pathways
for follow-up (e.g., Goeman et al., 2005); other prediction-based methods are designed to build multivariate
regression models (e.g., Wang et al., 2009).
With a few exceptions (e.g., Wei and Li, 2007; Luan and Li, 2008), most existing methods focus pri-
marily on linear effects; however, it is likely that biological pathways have more complex, nonlinear signals
due to the presence of feedback loops, signal cascades and/or gene-gene interactions. Kernel machine (KM)
modeling is an attractive tool for quantifying complex pathway effects because it allows for non-linear ef-
fects without explicitly specifying the forms of those effects. When there is a single pathway of interest,
methods have been developed to model pathway effects for non-censored outcomes (Liu et al., 2007, 2008);
for censored survival outcomes, KM methods have been proposed for the Cox proportional hazards model
(Li and Luan, 2003; Cai et al., 2011) and for the accelerated failure time (AFT) model (Liu et al., 2010; Sinnott
and Cai, unpublished). When there are multiple pathways under investigation and some of the pathways
may not relate to the event outcome of interest, it is important to select informative pathways for prediction,
and efﬁciently estimate their joint effects. Here, we propose using the KM framework to leverage pathway
structures via multiple kernel learning (MKL) (Bach et al., 2004; Lanckriet et al., 2004a) to incorporate mul-
tiple pathways. MKL has been proposed in the literature to aggregate information from various types of
47genetic data (Lanckriet et al., 2004b; Sonnenburg et al., 2006) for analyzing non-censored outcomes.
In this paper, we propose the use of the MKL framework under various survival models to construct
accurate risk prediction rules for censored survival outcomes. In Section 3.2, we derive our methods for a
general survival modeling framework with a convex objective function L0 and propose the use of quadratic
approximation for easy computation. In Section 3.3, we illustrate these methods for (i) the Cox model, with
L0 being the log partial likelihood; and (ii) the AFT model, with L0 being the smoothed Gehan objective
function. We demonstrate the procedure using the AFT model in simulation (Section 3.4) and in a data
analysis application to a breast cancer gene expression data set (Section 3.5). Concluding remarks are in
Section 3.6.
3.2 Approach with a General Objective Function
Let T denote the survival time, D the pD × 1 vector of clinical covariates, and Z the pZ × 1 vector of
genomic measurements. Due to censoring, we observe X =m i n {T,C} and ∆ = I{T ≤ C}, where C is a
censoring time that is assumed to be independent of T given W =( D
T,Z
T)
T. The observed data consist
of n independent and identically distributed (iid) random vectors, O = {(Xi,∆i,W
T
i):i =1 ,...,n}.W e
assume that the genomic covariates Z are grouped into M pathways with the mth pathway denoted by Zm;
we further assume that these pathways are disjoint.
3.2.1 Kernel Machine Modeling
Suppose the overall effect of W on T can be summarized as
µ(θ0,h =( h1,...,h M)) = θ
T
0D + h1(Z1)+···+ hM(ZM) (3.1)
where θ0 ∈ RpD, and the hm(·) are centered, smooth functions quantifying the pathway effect for the
mth pathway for m =1 ,...,M.We assume that each hm ∈ HKm, the Hilbert space generated by some
positive deﬁnite kernel Km(·,·;ρm). A kernel K is a measure of similarity between two vectors of genomic
measurements, and may depend on a possibly unknown scaling parameter ρ. Different choices of kernel
will yield different collections of possible functions h(·). For example, the linear kernel K(z1,z2)=z
T
1z2
leads to h(z)=β
Tz, a linear function of the covariates. To allow for complex non-linear effects, one may
consider the Gaussian kernel, deﬁned by K(z1,z2;ρ)=e x p {−￿z1−z2￿2/ρ}; the resulting function space HK
48is generated by the radial basis functions. For notational simplicity, we will suppress ρ from K, but will
discuss selection of ρ when needed.
Suppose a proper convex objective function such as a partial likelihood function, denoted by L0(θ0,h),
exists for estimating the unknown parameters. To incorporate potentially high dimensionality in h, one
may obtain estimators for (θ0,h) by minimizing a penalized objective function
L(θ0,h)=L0(θ0,h)+
c2
2
M ￿
m=1
￿hm￿2
HKm
where ￿h￿HK is the norm of h in HK and c is a tuning parameter. The norm of h quantiﬁes the smoothness
of h, with smaller values reﬂecting a smoother function. To further leverage pathway structure and enable
pathway selection, we take a MKL approach and further penalize L(θ0,h) by the sum of the norms of the
hm:
LMKL(θ0,h)=L(θ0,h)+
M ￿
m=1
λm￿hm￿HKm.
Each λm is a tuning parameter associated with the mth pathway. This penalty has the effect of setting
some pathway effects to 0. When the spaces HKm are linearly dependent, the individual pathway effects
h1,...,h M may not be identiﬁable even when the overall effect h￿(z)=h1(z)+···+ hM(z) is. Because we
want pathway-level information, we will assume the spaces HKm are linearly independent, in which case
the effect h￿ has a unique decomposition h￿ = h1 +···+hM for hm ∈ HKm. This is a reasonable assumption
when the pathways are disjoint as we assume here, but may not be reasonable in a setting with overlapping
pathways.
In Lemma 1 in the Appendix, we mimic the proof of the representer theorem (Kimeldorf and
Wahba, 1970) in Scholkopf and Smola (2002) to argue that for any θ0, the minimizers (￿ h1,...,￿ hm) of
LMKL(θ0,h) take a dual form ￿ hm(z)=
￿n
i=1 αmiKm(z,zi). Using the dual representation, the vec-
tor ￿ hm =( ￿ hm(z1),...,￿ hm(zn))
T = Kmαm, where Km is the matrix with (i,j)th entry Km(zi,zj), and
￿￿ hm￿2
HKm = α
T
mKmαm, so we may rewrite LMKL as a function of α =( α
T
1,...,α
T
M)
T and θ0 :
LMKL(θ0,α)=L(θ0,α)+
M ￿
m=1
λm
￿
αT
mKmαm. (3.2)
We may further rewrite this by employing a spectral decomposition for Km. If we let the eigenvalues and
associated eigenvectors of Km be ￿ ηml and ￿ ζml respectively, for l =1 ,...,n,where we assume that ￿ ηm1 ≥
··· ≥ ￿ ηmn and that the ￿ ζml are orthogonal with norm 1, then we may write Km = ￿ Bm￿ B
T
m, where ￿ Bm =
￿￿
￿ ηm1￿ ζm1 ···
￿
￿ ηmn￿ ζmn
￿
. Then ￿ hm = ￿ Bmθm, where θm = ￿ B
T
mαm, and letting θ =( θ
T
0,θ
T
1,...,θ
T
M)
T,
49LMKL(θ0,α) becomes:
LMKL(θ)=L(θ)+
M ￿
m=1
λm
￿
θT
mθm. (3.3)
3.2.2 Kernel PCA
One motivation for using a KM approach is to gain power to detect signal in the data; however, each αm in
(3.2) has n components, so by using KMs, we have introduced a large number of parameters, which may
cause a loss in power. Parametrizing the problem in terms of the θm does not ﬁx this problem because
each θm also has n components, but this parametrization relates to the primal representation of hm in the
Hilbert space HKm, and leads to a natural strategy for dimension reduction through kernel PCA (Mika
et al., 1999; Sch¨ olkopf et al., 1998). Speciﬁcally, each space HK has a (possibly inﬁnite) basis of orthonormal
eigenfunctions ζl(·) and eigenvalues ηl of the integral transform T : HK → HK deﬁned by [Tf](z)=
￿
K(z,z￿)f(z￿)dz￿, where η1 ≥ η2 ≥ ···. Any function h ∈ HK may be written in its primal representation,
h(z)=
￿∞
l=1 θl
√
ηlζl(z), and if the eigenvalues decay quickly, can be well-approximated by a truncated sum
hr0(z)=
￿r0
l=1 θl
√
ηlζl(z) for some sufﬁciently large r0. Moreover, it has been shown that the eigenvalues
and eigenvectors obtained based on K can be used to consistently estimate the underlying true eigenvalues
and eigenfunctions of HK (Koltchinskii and Gin´ e, 2000; Braun, 2005). Thus, by estimating the coefﬁcients
θm, we are estimating h in its approximate primal form, and when the eigenvalues decay quickly, we may
not lose much information by estimating h using only the ﬁrst rm eigenvectors, where rm is the smallest
number for which
￿rm
i=1 ￿ ηmi/
￿n
i=1 ￿ ηmi ≥ p for a prespeciﬁed fraction p. Ideally, the included eigenvectors
encode aspects of maximal variability in the data, while the excluded eigenvectors capture noise. This
approximation is called the kernel PCA approximation, and it can greatly reduce the number of unknown
parameters being estimated because rm is frequently signiﬁcantly smaller than n.
Writing the truncated matrices ￿ Bmrm =
￿￿
￿ ηm1￿ ζm1 ···
￿
￿ ηmrm ￿ ζmrm
￿
, we replace Km by Kmrm =
￿ Bmrm￿ B
T
mrm in (3.2). For notational simplicity, however, we will continue to write αm and θm for the co-
efﬁcients associated with these approximated matrices; since we recover ￿ Bm and Km by taking p =1 , the
kernel PCA formulation is in fact simply more general. Thus, we proceed with LMKL(θ) in (3.3) as our
objective function, keeping in mind that we may be using a kernel PCA approximation.
503.2.3 Least Squares Approximation
The penalty in (3.3) is equivalent to the group lasso penalty; the equivalence between MKL and the group
lasso has been noted in Bach (2008). Methods for ﬁtting a model with this penalty have been worked
out for linear and logistic regression (Yuan and Lin, 2006; Meier et al., 2008). Rather than developing the
machinery to minimize (3.3) for speciﬁc functions L(θ), we propose to approximate L(θ) via a quadratic
approximation similar to those proposed in Wang and Leng (2007) and Zhang and Lu (2007). In our setting,
we ﬁrst consider the Taylor series expansion of L(θ) about its minimizer ￿ θ :
L(θ) ≈ L(￿ θ)+ ˙ L(￿ θ)
T(θ − ￿ θ)+
1
2
(θ − ￿ θ)
T¨ L(￿ θ)(θ − ￿ θ).
where ˙ L(·) and ¨ L(·) are the ﬁrst- and second-order derivatives with respect to θ. The term L(￿ θ) is constant,
and ˙ L(￿ θ)=0since ￿ θ minimizes L(θ), so we may approximate the original objective function near ￿ θ by the
quadratic function:
1
2
(θ − ￿ θ)
T¨ L(￿ θ)(θ − ￿ θ).
Thus, near ￿ θ, minimizing LMKL(θ) is equivalent to minimizing
Q(θ)=
1
2
(θ − ￿ θ)
T¨ L(￿ θ)(θ − ￿ θ)+
M ￿
m=1
λm
￿
θT
mθm.
This minimization may be done using existing software for the group lasso for linear regression applied to
pseudodata. Speciﬁcally, by taking the squareroot matrix of ¨ L(￿ θ), say ¨ L(￿ θ)= ￿ X
T
pseudo ￿ Xpseudo, and letting
￿ Ypseudo = ￿ Xpseudo￿ θ, we have:
Q(θ)=
1
2
( ￿ Xpseudoθ − ￿ Ypseudo)
T( ￿ Xpseudoθ − ￿ Ypseudo)+
M ￿
m=1
λm
￿
θT
mθm.
a standard least squares formulation.
Minimizing Q(θ) will result in an estimator ￿ θ where some pathways may have had all coefﬁcients set
to 0. We could now use ￿ θ as our estimate of θ, or we could iterate the procedure, restricting the data to the
retained pathways to re-estimate ￿ θ the minimizer of L(θ), and minimizing Q(θ) centered at this ￿ θ. We could
repeat until the collection of pathways has stabilized. We compare the results of this iterative procedure to
the results of using the ﬁrst estimated ￿ θ.
3.2.4 Kernel Selection and Tuning
To implement the procedure, we need to select a kernel Km for each pathway, select a tuning parameter ρm
if the kernel requires it, select the ridge-type penalty parameter c in L(θ), and select the group lasso penalty
51parameters λm.
To select a kernel, researchers may use subject matter knowledge to decide on which kernel best cap-
tures similarity in their data. They may also be guided by what scope of models they wish to consider (e.g.,
linear or nonlinear). If several kernels are of interest, it may be desirable to have a data-driven approach
to kernel selection. For both the Cox and AFT models considered later on, KM pathway tests have been
developed to test the null hypothesis H0 : hm(·)=0in a marginal model relating survival to θ
T
0D+hm(Zm)
(Cai et al., 2011; Sinnott and Cai, unpublished). In these settings, one may perform the marginal test for
different kernels of interest and use the kernel which yields the smallest p-value. We may also use these
marginal KM pathway tests to select tuning parameters ρm. We can test H0 : hm(·)=0in the marginal
pathway model for different ρm, and use the value of ρm that corresponds to the smallest p-value.
To choose the ridge-type tuning parameter c in L(θ), we propose using the value of c which minimizes
a modiﬁed Bayesian Information Criterion (BIC) type penalty deﬁned by:
BIC(θ(c)) = −2log ￿ lik(θ(c)) + ￿ df(c)n0.1,
where ￿ lik(θ) is an estimate of the likelihood at θ, whose form will depend on the model, and ￿ df(c) is an
estimate of the degrees of freedom, given by ￿ df(c)=trR(c),
R(c)=￿ W
T￿ W
￿
￿ W
T￿ W + n
c2
2
Ip ￿ W
￿−1
where ￿ W is the n × p￿ W matrix with ith row ￿ Wi =( D
T
i, ￿ B
T
1i,...,￿ B
T
Mi)
T for ￿ Bmi the ith row of ￿ Bmrm, and
p￿ W = pD +
￿M
m=1 rm. Here, n0.1 is chosen to replace log(n) to improve the prediction performance in ﬁnite
sample since log(n) ￿ n0.1 and the standard BIC criterion tends to bias the ﬁt too far towards the null.
To choose the group lasso-type tuning parameters λm, we propose a standard adaptive group lasso
penalty, λm = λ/￿￿ θm(c)￿, where ￿θ￿ =
√
θTθ. To select λ, we again use a modiﬁed BIC penalty deﬁned by:
BIC(θ(λ)) = −2log ￿ lik(θ(λ)) + ˜ df(θ(λ))n0.1.
Here, ˜ df(θ(λ)) is an estimate of the degrees of freedom similar to that suggested in the group lasso literature:
˜ df(θ)=
M ￿
m=1
I{￿θm￿ > 0} +
M ￿
m=1
￿θm￿
￿￿ θm(c)￿
(￿ dfm(c) − 1).
and we once again replace log(n) by n0.1 since the standard BIC criterion tends to set too many pathways
to be non-informative. The quantity ￿ dfm(c) is an estimate of the degrees of freedom in the mth pathway,
found by summing the diagonal entries of R(c) associated with the mth pathway.
523.2.5 Pathway Screening
When the number of pathways is large, the number of components in θ can become quite large even af-
ter using kernel PCA approximations, and the problem can become computationally difﬁcult. When it is
reasonable to hypothesize that the number of biological pathways related to survival is much smaller than
the total number of pathways under consideration and when there is a marginal pathway test available for
the model of interest, it may be reasonable to perform a preliminary screening test, where each pathway is
tested marginally and only retained if the pathway p-value passes some FWER or FDR threshold.
3.3 Examples
3.3.1 Cox Model
The Cox PH KM model with M pathways assumes:
λi(t)=λ0(t)exp{θ
T
0Di + h1(Z1i)+···+ hM(ZMi)},i=1 ,...,n
where λi(t) is the hazard that person i has an event at time t given their covariates Wi and λ0(t) is a
common baseline hazard function. Deﬁning the usual counting and at risk processes Ni(t)=∆iI{Xi ≤ t}
and Yi(t)=I{Xi ≥ t}, we can let L(θ) be the penalized log partial likelihood function:
L(θ)=
n ￿
i=1
￿ ￿
θ
T￿ Wi − log
￿
S(0)(θ,s)}
￿￿
dNi(s)+
c2
2
M ￿
m=1
θ
T
mθm.
where S(k)(θ,s)=
￿n
l=1 Yl(s)exp{θ
T￿ Wl}￿ W
⊗k
l . Then:
¨ L(θ)=
n ￿
i=1
￿ ￿
S(2)(θ,s)
S(0)(θ,s)
−
S(1)(θ,s)⊗2
S(0)(θ,s)2
￿
dNi(s)+c2G
where G is the diagonal matrix whose ﬁrst pD diagonal entries are 0 and whose remaining r￿ diagonal
entries are 1. KM testing for individual pathways can be done using the method developed in Cai et al.
(2011). We can use L(θ) as the likelihood in BIC calculations.
3.3.2 AFT model
The AFT-KM model with M pathways assumes:
logTi = θ
T
0Di + h1(Z1i)+···+ hM(ZMi)+Ei,i=1 ,...,n (3.4)
53where Ei is an iid error term independent of Wi =( Di,
T Z
T
i)
T with completely unspeciﬁed distribution.
For this model, we can let L(θ) be the penalized Gehan objective function:
L(θ)=n−2
n ￿
i=1
n ￿
j=1
∆i|￿ ej(θ) − ￿ ei(θ)|+ +
c2
2
M ￿
m=1
θ
T
mθm (3.5)
where ￿ ei(θ) = logXi − θ
T￿ Wi. Unfortunately, this objective function is only once differentiable, so our
procedure does not directly apply. To remedy this, we perform a smoothing step, following reasoning
similar to that in Brown and Wang (2007). Speciﬁcally, the gradient of L(θ) is:
˙ L(θ)=n−2
n ￿
i=1
n ￿
j=1
∆i(￿ Wi − ￿ Wj)I{￿ ej(θ) − ￿ ei(θ) > 0} + c2Gθ (3.6)
where G is the diagonal matrix whose ﬁrst pD diagonal entries are 0 and whose remaining r￿ diagonal en-
tries are 1. The function ˙ L has jumps because of the indicator function I{·}, so to smooth ˙ L we could replace
I{￿ ej(θ) − ￿ ei(θ) > 0} by Φ
￿
ej(θ)−ei(θ)
σn
￿
where Φ is some continuous cdf and σn is a bandwidth parame-
ter. Here, we will take Φ to be the standard normal cdf, and use as a bandwidth σn = s.d.{ej(￿ θ)} × n− 1
3.
We choose this bandwidth with under-smoothing to eliminate the potential bias induced by smoothing
(van der Vaart, 1994). Our smoothed version of ˙ L is ˙ Lsm :
˙ Lsm(θ)=n−2
n ￿
i=1
n ￿
j=1
∆i(￿ Wi − ￿ Wj)Φ
￿
ej(θ) − ei(θ)
σn
￿
+ c2Gθ (3.7)
We can now take a further derivative:
¨ Lsm(θ)=
∂
∂(θ)T
˙ Lsm(θ)=n−2
n ￿
i=1
n ￿
j=1
∆i
σn
φ
￿
￿ ej(θ) − ￿ ei(θ)
σn
￿
(￿ Wi − ￿ Wj)(￿ Wi − ￿ Wj)
T + c2G (3.8)
Finally, we can check that ˙ Lsm(θ) is the gradient of the smoothed Gehan objective function deﬁned by:
Lsm(θ)=n−2
n ￿
i=1
n ￿
j=1
∆i
￿
(ej(θ) − ei(θ))Φ
￿
ej(θ) − ei(θ)
σn
￿
+ σφ
￿
ej(θ) − ei(θ)
σn
￿￿
+
c2
2
M ￿
m=1
θ
T
mθm
KM testing for individual pathways can be done using the method developed in Sinnott and Cai
(unpublished). We can use the log sieve likelihood estimate (Zeng and Lin, 2007) in place of the likelihood
in BIC calculations.
3.4 Simulation Studies
To assess the performance of the estimation procedure, we conducted simulation studies. We considered
settings with M = 10 and M = 20 total pathways, with each pathway of size P =5or P = 10. Three
54pathways were related to outcome, while the remaining pathways were noise; and when a pathway was
related to outcome, all genes in the pathway were involved. The genes were simulated from a multivariate
normal with mean 0 and variance 1, and blockwise compound symmetry; we considered within pathway
correlation of 0.2 and 0.4, and between pathway correlation of 0 and 0.1. The underlying relationship be-
tween the associated pathways and survival was either linear or nonlinear, with all three pathways having
the same signal. We considered sample size N = 200, % censoring 25%, and for simplicity, no additional
covariates.
Table 3.1: Simulated data with 3 related pathways with all genes involved in a linear signal, remaining
pathways unrelated. Shown are results from 10 and 20 paths of size 5 and 10, for different levels of between-
and within-pathway correlation, for linear kernel (L) and Gaussian kernel (G). Compared are the C-statistic
for the AFT lasso (C lasso), the initial KM ﬁt with ridge penalty (C ridge), and the KM ﬁt after one iteration
of group selection (C MKL). Also shown is the C from the oracle ﬁt (C oracle), as well as the number of
genes for the AFT lasso (N genes lasso) and the KM ﬁt (N genes MKL).
Path Size 5
N paths 10 20
bt Correlation 0 0.1 0 0.1
wi Correlation 0.2 0.4 0.2 0.4 0.2 0.4 0.2 0.4
Kernel L G L G L G L G L G L G L G L G
C lasso 71 72 76 76 77 77 79 80 65 65 72 72 73 73 79 78
C ridge 71 71 75 74 76 76 78 77 63 64 69 70 70 72 74 75
C MKL 73 73 77 76 78 78 80 79 66 66 73 73 74 75 79 79
C oracle 75 74 78 77 79 78 81 79 71 70 78 77 77 76 81 80
N genes lasso 28.1 25.8 25.3 24.7 24 23.1 22.6 21.9 60.8 61.4 54.4 57.8 40.7 38.9 38.6 33
N genes MKL 33.6 28.7 32.8 32.8 30.7 27 31.1 31.4 87.7 69.7 87.9 80.4 72 48.6 81.2 61.5
Path Size 10
C lasso 75 76 83 82 84 84 86 86 70 70 81 80 84 85 88 88
C ridge 73 79 81 83 81 85 83 85 68 77 74 82 78 84 79 86
C MKL 77 80 84 84 85 86 85 86 68 80 75 85 82 87 83 88
C oracle 79 80 85 85 86 86 86 86 81 82 87 87 87 88 88 88
N genes lasso 58.4 58.4 47.7 50.6 39.9 39 37 35 154.7 154.5 114.7 121.6 62.1 64.8 42.6 43.4
N genes MKL 94.7 57.7 89.1 57.8 86.4 50 84 50 200 124.2 200 150.7 170.6 95 191.2 80
We considered ﬁtting all pathways with linear kernel, which requires no tuning, or with Gaussian
kernel, which depends on a tuning parameter ρ selected as the one producing the smallest p-value from the
55test in Sinnott and Cai (unpublished). Kernel PCA was used with p =0 .95. As a gold standard, we ﬁt the
“oracle” model, where we restricted the ﬁt to the pathways known to be involved, as well as an AFT model
with standard adaptive lasso penalty, which is ﬁt using a quadratic approximation to the likelihood similar
to that described above.
Results from simulations with linear signal are shown in Table 3.1. When the pathways are of size 5,
the KM method tends to improve slightly over the lasso. The linear and Gaussian kernels tend to perform
very similarly. When the pathway size increases to 10, we see a slightly greater amount of improvement of
the KM method over the lasso when the Gaussian kernel is used. Results from simulations with nonlinear
signal are shown in Table 3.2. Here, the linear KM method performs very similarly to the Lasso as we
might expect, while the KM method with Gaussian kernel improves often substantially over the lasso. This
suggests that our method may improve risk prediction when the signal is nonlinear.
When we let the procedure iterate until the number of pathways stabilized, the stabilization usually
happened after a single iteration and so did not alter the ﬁt. Thus, we recommend using a single iteration,
since it is faster and the iteration never improved the C statistic.
Overall, the KM approach with Gaussian kernel performs well. The most notable drawback is that the
pathway-based models tend to be larger than the lasso models; in some settings the pathway-based method
is selecting all the pathways. We might be able to improve this with a more stringent approach to tuning.
3.5 Example: Breast Cancer Gene Expression Study
Genomic information has already improved our understanding of breast cancer. A number of gene expres-
sion signatures have been introduced into clinical practice to better identify cancers with high and low risk
ofrecurrence(Desmedtetal.,2011). Despitetheseadvances, approximately60%ofpatientswithearly-stage
breast cancer are given adjuvant therapy in addition to local treatment, while only a small proportion are
thought to beneﬁt (Reis-Filho and Pusztai, 2011). Better markers of aggressive disease would help physi-
cians predict which patients could safely avoid adjuvant therapy and its negative side-effects, and which
patients should be treated with more aggressive therapy.
One promising hypothesis-driven approach is to investigate the effects of candidate pathways on
recurrence-free survival. We collected 32 candidate pathways from the molecular signature database. Some
of the pathways overlapped, but we ignored the overlap for the purpose of this analysis.
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pathways unrelated. Shown are results from 10 and 20 paths of size 5 and 10, for different levels of between-
and within-pathway correlation, for linear kernel (L) and Gaussian kernel (G). Compared are the C-statistic
for the AFT lasso (C lasso), the initial KM ﬁt with ridge penalty (C ridge), and the KM ﬁt after one iteration
of group selection (C MKL). Also shown is the C from the oracle ﬁt (C oracle), as well as the number of
genes for the AFT lasso (N genes lasso) and the KM ﬁt (N genes MKL).
Path Size 5
N paths 10 20
bt Correlation 0 0.1 0 0.1
wi Correlation 0.2 0.4 0.2 0.4 0.2 0.4 0.2 0.4
Kernel L G L G L G L G L G L G L G L G
C lasso 59 60 59 59 60 61 60 61 56 55 54 54 57 55 56 55
C ridge 57 69 57 73 58 70 58 74 55 63 53 67 55 68 54 68
C MKL 58 70 59 74 60 71 60 75 56 65 54 69 57 70 56 70
C oracle 61 72 61 76 62 72 63 77 60 70 58 74 61 75 61 75
N genes lasso 18.8 14.5 17.8 18.3 19.4 14.6 18.6 19.2 58 56.7 61 60.9 53.5 53.7 54 54.5
N genes MKL 33.7 34.7 32.7 34.3 35 32.2 36.6 35 88.7 76.7 92.8 77.5 87.2 60.3 90.5 80.8
Path Size 10
C lasso 56 57 56 57 59 59 58 58 53 54 53 54 55 55 56 56
C ridge 56 60 55 68 57 64 57 70 53 56 53 66 54 61 54 66
C MKL 57 60 57 69 59 62 59 70 53 57 53 68 54 57 55 67
C oracle 61 63 60 70 63 66 62 71 59 61 59 70 61 65 61 70
N genes lasso 61.1 53.1 54.1 49.9 50.8 49.9 51.8 50.8 163.8 167.8 162.5 152.6 126.1 133.1 106.3 114
N genes MKL 96.8 44.8 95 62.4 95.6 40 92.9 63.3 200 106.7 187.5 141.8 200 67.9 199.3 156
To assess the effects of these pathways on breast cancer progression, we applied our AFT KM marginal
pathway test with the Gaussian kernel to each of the pathways in a training set of 286 lymph node nega-
tive breast cancer patients who received no systemic adjuvant therapy (Wang et al., 2005). We used tumor
gene expression assessed on the Affymetrix U133a Gene Chip. A total of 107 deaths or recurrences were
observed, with follow-up time ranging between 2 months and 14.3 years (median 7.2 years); 63% of ob-
servations were censored. We screened pathways at a family-wise error rate of 5%, and used the test to
determine which value of the Gaussian kernel tuning parameter ρm to use for each pathway. Nine path-
ways were retained from this screening. We then used our MKL procedure to ﬁt a model selecting from
among these nine pathways; all of the pathways were retained for the ﬁnal model. We applied the result-
57ing model to an independent validation set of 119 lymph node negative patients with no adjuvant therapy,
with gene expression assessed on the same chip (Sotiriou et al., 2006). In this validation set, 27 deaths
or recurrences were observed, with follow-up time ranging between 2 months and 14.5 years (median 7.7
years); 77% of observations were censored. We assessed the accuracy of each model using the C-statistic
and calculated 95% conﬁdence intervals (Uno et al., 2011). Our ﬁnal model produced a C-statistic in the
validation set of 66% (95% CI: 54% - 79%).
For comparison, we ﬁt a Cox model with the lasso penalty to the training data, using the 788 genes
in the candidate pathways. We did this instead of the AFT model with the lasso penalty ﬁt in simulations
because that procedure becomes computationally burdensome when the number of features becomes very
large. The Cox model yielded a C-statistic in the validation data of 64% (95% CI: 52% - 77%), which is very
similar to the results of our MKL procedure.
3.6 Discussion
In this paper, we proposed KM based procedures to build a risk prediction model by selecting and com-
bining information from multiple pathways. By taking a pathway based approach, we take advantage of
pre-existing biological knowledge and privilege groups of genes believed to work together. By working
with the Gaussian kernel, we can capture both linear and nonlinear effects well. When the underlying sig-
nal is sparse with only a few genes in a pathway associated with survival, it would also be interesting to
extend our proposed procedure to allow for feature selection under the KM framework. In reality, biolog-
ical pathways overlap, so our assumption that pathways are disjoint will generally not be true in practice.
Based on existing literature about overlapping group lasso (Jacob et al., 2009), our method should extend
easily to the situation where pathways overlap if we change the norm we use to penalize pathways; the
computational methods should not change. We hope to elaborate on this in the future. The model as cur-
rently formulated also assumes that genes cannot interact between pathways, but it would be interesting to
extend the method to allow this to occur.
583.7 Appendix
Lemma 1. For ﬁxed θ0,c ,and λm, the minimizers ￿ hm(z) of
LMKL(θ0,h)=L(θ0,h)+
c2
2
M ￿
m=1
￿hm￿2
HKm +
M ￿
m=1
λm￿hm￿HKm
take a dual form ￿ hm(z)=
￿n
i=1 αmiKm(z,zi).
Proof. For ﬁxed θ0,c ,and λm, let h be a minimizer of LMKL(θ0,h). For each m, let Vm =
span{Km(z1,·),...,K m(zn,·)} and decompose HKm = Vm ⊕V ⊥
m. Decompose hm = hVm +hV ⊥
m,h Vm ∈ Vm,
hV ⊥
m ∈ V ⊥
m.
Claim 1: The value of L(θ0,h) does not depend on hV ⊥
m. This is because L(θ0,h) depends only on hm
evaluated at the observed data z1,···,zn, and hm ∈ HKm implies that:
hm(zj)=￿hm(·),K m(zj,·)￿
= ￿hVm(·)+hV ⊥
m(·),K m(zj,·)￿
= ￿hVm(·),K m(zj,·)￿ + ￿hV ⊥
m(·),K m(zj,·)￿
= hVm(zj)+0 .
Claim 2: The value of ￿hm￿2
HKm is smallest when hV ⊥
m(·)=0 . This is because by orthogonality:
￿hm￿2
HKm = ￿hVm￿2
HKm + ￿hV ⊥
m￿2
HKm.
Thus the minimizers satisfy hm ∈ Vm, so that hm(z)=
￿n
i=1 αmiKm(zi,z).
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